[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Next Issue
Volume 6, January
Previous Issue
Volume 5, November
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 

Toxins, Volume 5, Issue 12 (December 2013) – 20 articles , Pages 2293-2685

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
959 KiB  
Article
In Vitro Glucuronidation of Ochratoxin A by Rat Liver Microsomes
by Zheng Han, Emmanuel K. Tangni, José Diana Di Mavungu, Lynn Vanhaecke, Sarah De Saeger, Aibo Wu and Alfons Callebaut
Toxins 2013, 5(12), 2671-2685; https://doi.org/10.3390/toxins5122671 - 18 Dec 2013
Cited by 21 | Viewed by 8863
Abstract
Ochratoxin A (OTA), one of the most toxic mycotoxins, can contaminate a wide range of food and feedstuff. To date, the data on its conjugates via glucuronidation request clarification and consolidation. In the present study, the combined approaches of ultra high performance liquid [...] Read more.
Ochratoxin A (OTA), one of the most toxic mycotoxins, can contaminate a wide range of food and feedstuff. To date, the data on its conjugates via glucuronidation request clarification and consolidation. In the present study, the combined approaches of ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS), UHPLC-Orbitrap-high resolution mass spectrometry (HRMS) and liquid chromatography-multiple stage mass spectrometry (LC-MSn) were utilized to investigate the metabolic profile of OTA in rat liver microsomes. Three conjugated products of OTA corresponding to amino-, phenol- and acyl-glucuronides were identified, and the related structures were confirmed by hydrolysis with ?-glucuronidase. Moreover, OTA methyl ester, OT? and OT?-glucuronide were also found in the reaction solution. Based on these results, an in vitro metabolic pathway of OTA has been proposed for the first time. Full article
(This article belongs to the Special Issue Recent Advances in Ochratoxins Research)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Full scan chromatograph of the Reaction 1 solution in positive electrospray ionization (ESI<sup>+</sup>) mode.</p>
Full article ">Figure 2
<p>Product ion spectra of Compound 1 (<b>a</b>); Compound 2 (<b>b</b>); Compound 3 (<b>c</b>); and Compound 4 (<b>d</b>) using ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).</p>
Full article ">Figure 3
<p>MS<sup>n</sup> spectra of Compounds 1–3 (a, b, c) and Compound 4 (d, e, f). (<b>a</b>) MS<sup>2</sup> (+) 580; (<b>b</b>) MS<sup>3</sup> (+) 580→562; (<b>c</b>) MS<sup>4</sup> (+) 580→562→404; (<b>d</b>) MS<sup>2</sup> (+) 418; (<b>e</b>) MS<sup>3</sup> (+) 418→386; (<b>f</b>) MS<sup>4</sup> (+) 418→386→358 using LC ion trap MS.</p>
Full article ">Figure 4
<p>The proposed fragmentation pathways for Compounds 1–3.</p>
Full article ">Figure 5
<p>The proposed metabolic pathway for ochratoxin A (OTA) via glucuronidation by rat liver microsomes.</p>
Full article ">
1479 KiB  
Article
Occurrence of Deoxynivalenol and Deoxynivalenol-3-glucoside in Hard Red Spring Wheat Grown in the USA
by Senay Simsek, Maribel Ovando-Martínez, Bahri Ozsisli, Kristin Whitney and Jae-Bom Ohm
Toxins 2013, 5(12), 2656-2670; https://doi.org/10.3390/toxins5122656 - 18 Dec 2013
Cited by 18 | Viewed by 6274
Abstract
Deoxynivalenol (DON) is a mycotoxin found in wheat that is infected with Fusarium fungus. DON may also be converted to a type of “masked mycotoxin”, named deoxynivalenol-3-glucoside (D3G), as a result of detoxification of the plant. In this study, DON and D3G were [...] Read more.
Deoxynivalenol (DON) is a mycotoxin found in wheat that is infected with Fusarium fungus. DON may also be converted to a type of “masked mycotoxin”, named deoxynivalenol-3-glucoside (D3G), as a result of detoxification of the plant. In this study, DON and D3G were measured using gas chromatographic (GC) and liquid chromatography-mass spectrometry (LC-MS) in wheat samples collected during 2011 and 2012 in the USA. Results indicate that the growing region had a significant effect on the DON and D3G (p < 0.0001). There was a positive correlation between both methods (GC and LC-MS) used for determination of DON content. DON showed a significant and positive correlation with D3G during 2011. Overall, DON production had an effect on D3G content and kernel damage, and was dependent on environmental conditions during Fusarium infection. Full article
(This article belongs to the Special Issue Recent Advances and Perspectives in Deoxynivalenol Research)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Distribution of hard red spring (HRS) wheat samples from the 2011 and 2012 Crop Surveys from Montana, North Dakota, Minnesota and South Dakota. <b>A</b>, <b>B</b>, <b>C</b>, <b>D</b>, <b>E</b> and <b>F</b>: regions in which the samples were collected from each state. The numbers inside the parenthesis represent the number of samples taken, from left to right: 2011 Crop Survey and 2012 Crop Survey.</p>
Full article ">Figure 2
<p>Correlation GC-DON and LC-MS DON content values. (<b>a</b>) 2011 survey samples; (<b>b</b>) 2012 survey samples and (<b>c</b>) 2011 and 2012 survey samples combined. *** Significantly different from 1 at <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 3
<p>Correlation between DON and D3G levels in survey samples between 2011 and 2012; where ***, and * indicate that regression coefficients are significant at <span class="html-italic">p</span> &lt; 0.001 and <span class="html-italic">p</span> &lt; 0.05, respectively.</p>
Full article ">Figure 4
<p>Correlation between GC-DON and damage levels in survey samples from (<b>a</b>) 2011 and (<b>b</b>) 2012.</p>
Full article ">Figure 5
<p>Representative chromatograms of a wheat sample containing approximately 2.0 mg/kg DON and 1.0 mg/kg D3G. (<b>a</b>) gas chromatography–electron capture detection (GC-ECD) chromatogram of DON * and Mirex ** (internal standard); (<b>b</b>) LC-MS extracted ion (m/z of (M + H) + ion 297.1333) chromatogram of DON; and (<b>c</b>) LC-MS extracted ion (m/z of the (M + Na) + ion 481.1680) chromatogram of D3G.</p>
Full article ">
9748 KiB  
Article
Venom Down Under: Dynamic Evolution of Australian Elapid Snake Toxins
by Timothy N. W. Jackson, Kartik Sunagar, Eivind A. B. Undheim, Ivan Koludarov, Angelo H. C. Chan, Kate Sanders, Syed A. Ali, Iwan Hendrikx, Nathan Dunstan and Bryan G. Fry
Toxins 2013, 5(12), 2621-2655; https://doi.org/10.3390/toxins5122621 - 18 Dec 2013
Cited by 54 | Viewed by 16296
Abstract
Despite the unparalleled diversity of venomous snakes in Australia, research has concentrated on a handful of medically significant species and even of these very few toxins have been fully sequenced. In this study, venom gland transcriptomes were sequenced from eleven species of small [...] Read more.
Despite the unparalleled diversity of venomous snakes in Australia, research has concentrated on a handful of medically significant species and even of these very few toxins have been fully sequenced. In this study, venom gland transcriptomes were sequenced from eleven species of small Australian elapid snakes, from eleven genera, spanning a broad phylogenetic range. The particularly large number of sequences obtained for three-finger toxin (3FTx) peptides allowed for robust reconstructions of their dynamic molecular evolutionary histories. We demonstrated that each species preferentially favoured different types of ?-neurotoxic 3FTx, probably as a result of differing feeding ecologies. The three forms of ?-neurotoxin [Type I (also known as (aka): short-chain), Type II (aka: long-chain) and Type III] not only adopted differential rates of evolution, but have also conserved a diversity of residues, presumably to potentiate prey-specific toxicity. Despite these differences, the different ?-neurotoxin types were shown to accumulate mutations in similar regions of the protein, largely in the loops and structurally unimportant regions, highlighting the significant role of focal mutagenesis. We theorize that this phenomenon not only affects toxin potency or specificity, but also generates necessary variation for preventing/delaying prey animals from acquiring venom-resistance. This study also recovered the first full-length sequences for multimeric phospholipase A2 (PLA2) ‘taipoxin/paradoxin’ subunits from non-Oxyuranus species, confirming the early recruitment of this extremely potent neurotoxin complex to the venom arsenal of Australian elapid snakes. We also recovered the first natriuretic peptides from an elapid that lack the derived C-terminal tail and resemble the plesiotypic form (ancestral character state) found in viper venoms. This provides supporting evidence for a single early recruitment of natriuretic peptides into snake venoms. Novel forms of kunitz and waprin peptides were recovered, including dual domain kunitz-kunitz precursors and the first kunitz-waprin hybrid precursors from elapid snakes. The novel sequences recovered in this study reveal that the huge diversity of unstudied venomous Australian snakes are of considerable interest not only for the investigation of venom and whole organism evolution but also represent an untapped bioresource in the search for novel compounds for use in drug design and development. Full article
(This article belongs to the Collection Evolution of Venom Systems)
Show Figures

Figure 1

Figure 1
<p>BEAST maximum credibility ultrametric tree for in-group taxa [<a href="#B12-toxins-05-02621" class="html-bibr">12</a>]. Node values indicate 95% highest posterior distributions for calibration points. Posterior probability support values are shown for each node. Species included in this study are indicated in red.</p>
Full article ">Figure 2
<p>Homology model depicting the locations of positively selected sites from various species, indicated by different colour codes. Multiple sequence alignment of Type II α-ntxs depicting the locations of positively selected sites is also presented. Representative sequences are from <span class="html-italic">Brachyurophis roperi</span> (1. GAHA01000012, 2. GAHA01000013, 3. GAHA01000016), <span class="html-italic">Cacophis squamulosus</span> (4. GAHB01000003, 5. GAHB01000008, 6. GAHB01000008), <span class="html-italic">Drysdalia coronoides</span> (7. FJ752483, 8. FJ752485, 9. FJ752487), <span class="html-italic">Hemiaspis signata</span> (10. GAHF01000010, 11. GAHF01000011, 12. GAHF01000014), <span class="html-italic">Parasuta nigriceps</span> (13. FJ790454, 14. FJ790448, 15. FJ790450), <span class="html-italic">Vermicella annulata</span> (16. GAHJ01000013, 17. GAHJ01000014, 18. GAHJ01000015). Numerical IDs representing species lacking unique mutations are indicated by strikethrough.</p>
Full article ">Figure 3
<p>Molecular evolution of Type I (aka: short-chain) α-neurotoxins. Three-dimensional homology models of Type I α-neurotoxins from various species, depicting the locations of positively selected sites (Model 8, <span class="html-italic">PP</span> ≥ 0.95, Bayes-Empirical Bayes approach) is presented here. Species are: (A) <span class="html-italic">Brachyurophis roperi</span>, (B) <span class="html-italic">Cacophis squamulosus</span>, (C) <span class="html-italic">Drysdalia coronoides</span>, (D) <span class="html-italic">Hemiaspis signata</span>, (E) <span class="html-italic">Parasuta nigriceps</span> and (F) <span class="html-italic">Vermicella annulata</span>.</p>
Full article ">Figure 4
<p>Homology model depicting the locations of positively selected sites from various species, indicated by different colour codes. Multiple sequence alignment of Type II α-ntxs depicting the locations of positively selected sites is also presented. Representative sequences are from <span class="html-italic">Acanthophis wellsi</span> (1. GAGZ01000001, 2. GAGZ01000004, 3. GAGZ01000006)<span class="html-italic">, Brachyurophis roperi</span> (4. GAHA01000003, 5. GAHA01000001, 6. GAHA01000002), <span class="html-italic">Drysdalia coronoides</span> (7. FJ481928, 8. FJ752461, 9. FJ752459), <span class="html-italic">Echiopsis curta</span> (10. GAHD01000001, 11. GAHD01000004, 12. GAHD01000006), <span class="html-italic">Furina ornata</span> (13. GAHE01000001, 14. GAHE01000009, 15. GAHE01000014), <span class="html-italic">Hemiaspis signata</span> (16. GAHF01000001, 17. GAHF01000005, 18. GAHF01000006), <span class="html-italic">Suta fasciata</span> (19. GAHI01000001, 20. GAHI01000004), 21. <span class="html-italic">Parasuta nigriceps</span> FJ790457, <span class="html-italic">Pseudonaja modesta</span> (22. GAHH01000040, 23. GAHH01000045, 24. GAHH01000046, 25. GAHH01000043, 26. GAHH01000042, 27. GAHH01000035) and <span class="html-italic">Vermicella annulata</span> (28. GAHJ01000009, 29. GAHJ01000010, 30. GAHJ01000016). Numerical IDs representing species lacking unique mutations are indicated by strikethrough.</p>
Full article ">Figure 5
<p>Molecular evolution of Type II (aka: long-chain) α-neurotoxins. Three-dimensional homology models of Type II α-neurotoxins from various species, depicting the locations of positively selected sites (Model 8, <span class="html-italic">PP</span> ≥ 0.95, Bayes-Empirical Bayes approach). Species are: (A) <span class="html-italic">Acanthophis wellsi</span>, (B) <span class="html-italic">Brachyurophis roperi</span>, (C) <span class="html-italic">Drysdalia coronoides</span>, (D) <span class="html-italic">Echiopsis curta</span>, (E) <span class="html-italic">Furina ornata</span>, (F) <span class="html-italic">Hemiaspis signata</span>, (G) <span class="html-italic">Parasuta nigriceps</span> and (H) <span class="html-italic">Pseudonaja modesta</span>.</p>
Full article ">Figure 6
<p>Structural and functional evolution of Type III α-neurotoxins. Multiple sequence alignment of Type III α-ntxs depicting the locations of positively selected sites (Model 8, <span class="html-italic">PP</span> ≥ 0.95, Bayes-Empirical Bayes approach) in various species of Australian elapids is presented here. Homology model depicting the locations of positively selected sites from various species, indicated by different colour codes, is also presented. Representative sequences are from <span class="html-italic">Brachyurophis roperi</span> (1. GAHA01000009, 2. GAHA01000010, 3. GAHA01000011), <span class="html-italic">Cacophis squamulosus</span> (4. GAHB01000009, 5. GAHB01000010, 6. GAHB01000011), <span class="html-italic">Furina ornata</span> (7. GAHE01000022, 8. GAHE01000023, 9. GAHE01000020, <span class="html-italic">Pseudonaja modesta</span> (10. GAHH01000009, 11. GAHH01000015, 12. GAHH01000022) and <span class="html-italic">Vermicella annulata</span> (13. GAHJ01000001, 14. GAHJ01000003, 15. GAHJ01000004). Numerical IDs representing species lacking unique mutations are indicated by strikethrough.</p>
Full article ">Figure 7
<p>Molecular evolution of Type III α-neurotoxins. Three-dimensional homology models of Type III α-neurotoxins from various species, depicting the locations of positively selected sites (Model 8, <span class="html-italic">PP</span> ≥ 0.95, Bayes-Empirical Bayes approach). Species are: (A) <span class="html-italic">Furina ornata</span>, (B) <span class="html-italic">Pseudonaja modesta</span> and (C) <span class="html-italic">Vermicella annulata</span>.</p>
Full article ">Figure 8
<p><b>Sequence alignment of natriuretic peptides</b>. (1). P68515 <span class="html-italic">Bothrops insularis</span>, (2). K4J3K2 <span class="html-italic">Azemmiops feae</span>, (3). K4IT20 <span class="html-italic">Azemmiops feae</span>, (4). A8YPR6 <span class="html-italic">Echis ocellatus</span>, (5). Q09GK2 <span class="html-italic">Philodryas olfersii</span>, (6). GAHI01000013 <span class="html-italic">Suta fasciata</span>, (7). P83228 <span class="html-italic">Oxyuranus scutellatus</span>, (8). GAHI01000016 <span class="html-italic">Suta fasciata</span>, (9). A8YPR9 <span class="html-italic">Cerastes cerastes</span> Post-translationally cleaved peptides in shaded in gray.</p>
Full article ">Figure 9
<p>Phylogenetic reconstruction of the molecular evolutionary history of natriuretic peptides. Non-toxin outgroup sequences (P23582 and P55207) not shown. Representative sequences obtained in this study are shown in red. Node labels indicate posterior probabilities.</p>
Full article ">Figure 10
<p>Sequence alignment of ‘taipoxin/paradoxin’-like presynaptic complex subunits: α-subunit (1). Q45Z43 <span class="html-italic">Oxyuranus microlepidotus</span>, (2). Q45Z48 <span class="html-italic">Oxyuranus scutellatus</span>, (3). GAGZ01000028 <span class="html-italic">Acanthophis wellsi</span>, (4). A6MFM9 <span class="html-italic">Rhinoplocephalus nigrescens</span>, (5). GAHI01000025 <span class="html-italic">Suta fasciata</span>, (6). B5G6G1 <span class="html-italic">Tropidechis carinatus</span>, β-subunit (7). Q45Z46 <span class="html-italic">Oxyuranus microlepidotus</span>, (8). Q45Z53 <span class="html-italic">Oxyuranus scutellatus</span>, (9). GAGZ01000024 <span class="html-italic">Acanthophis wellsi</span>, (10). GAHI01000027 <span class="html-italic">Suta fasciata</span> and γ-subunit (11). Q4VRI6 <span class="html-italic">Oxyuranus scutellatus</span>, (12). GAGZ01000027 <span class="html-italic">Acanthophis wellsi</span>, (13). Q9PUG7 <span class="html-italic">Austrelaps superbus</span>, (14). GAHI01000030 <span class="html-italic">Suta fasciata</span>.</p>
Full article ">Figure 11
<p>Phylogenetic reconstruction of the molecular evolutionary history of snake venom Type I phospholipase A<sub>2</sub> toxins. Non-toxin outgroup sequences (Q8JFB2 and Q8JFG2) not shown. Representatives of sequences obtained in this study are shown in red. Node labels indicate posterior probabilities.</p>
Full article ">Figure 12
<p>Sequence alignment of precursors encoding: <span class="underline">dual-domain kunitz</span> (1). B2BS84 <span class="html-italic">Austrelaps labialis</span>, (2). GAHG01000009 <span class="html-italic">Hoplocephalus bungaroides</span>; mono-domain kunitz (3). GAGZ01000019 <span class="html-italic">Acanthophis wellsi</span>, (4). GAGZ01000017 <span class="html-italic">Acanthophis wellsi</span>, (5). GAHB01000016 <span class="html-italic">Cacophis squamulosus</span>, (6). GAHD01000011 <span class="html-italic">Echiopsis curta</span>, (7). GAHG01000008 <span class="html-italic">Hoplocephalus bungaroides</span>, (8). GAHH01000051 <span class="html-italic">Pseudonaja modesta</span>, (9). GAHI01000010 <span class="html-italic">Suta fasciata;</span> <span class="underline">dual-domain waprin</span> (10). A7X4K1 <span class="html-italic">Philodryas olfersii</span>; <span class="underline">mono-domain waprin</span> (11). GAHC01000021 <span class="html-italic">Denisonia devisi</span>, (12). A7X4J4 <span class="html-italic">Rhabodophis tigrinus</span>, (13). A7X4K7 <span class="html-italic">Philodryas olfersii</span>, (14). A7X4I7 <span class="html-italic">Thrasops jacksonii</span>, (15). B5G6H4 <span class="html-italic">Notechis scutatus</span>, (16). B5G6G8 <span class="html-italic">Oxyuranus scutellatus</span>; <span class="underline">kunitz-waprin fusion</span> (17). D3U2B9 <span class="html-italic">Sistrurus catenatus edwardsii</span>, (18). D3U0D3 <span class="html-italic">Sistrurus catenatus tergeminus</span>, (19). GAHB01000034 <span class="html-italic">Cacophis squamulosus</span>, (20). GAHI01000009 <span class="html-italic">Suta fasciata.</span></p>
Full article ">
462 KiB  
Review
Towards Clinical Applications of Anti-endotoxin Antibodies; A Re-appraisal of the Disconnect
by James C. Hurley
Toxins 2013, 5(12), 2589-2620; https://doi.org/10.3390/toxins5122589 - 18 Dec 2013
Cited by 26 | Viewed by 9134
Abstract
Endotoxin is a potent mediator of a broad range of patho-physiological effects in humans. It is present in all Gram negative (GN) bacteria. It would be expected that anti-endotoxin therapies, whether antibody based or not, would have an important adjuvant therapeutic role along [...] Read more.
Endotoxin is a potent mediator of a broad range of patho-physiological effects in humans. It is present in all Gram negative (GN) bacteria. It would be expected that anti-endotoxin therapies, whether antibody based or not, would have an important adjuvant therapeutic role along with antibiotics and other supportive therapies for GN infections. Indeed there is an extensive literature relating to both pre-clinical and clinical studies of anti-endotoxin antibodies. However, the extent of disconnect between the generally successful pre-clinical studies versus the failures of the numerous large clinical trials of antibody based and other anti-endotoxin therapies is under-appreciated and unexplained. Seeking a reconciliation of this disconnect is not an abstract academic question as clinical trials of interventions to reduce levels of endotoxemia levels are ongoing. The aim of this review is to examine new insights into the complex relationship between endotoxemia and sepsis in an attempt to bridge this disconnect. Several new factors to consider in this reappraisal include the frequency and types of GN bacteremia and the underlying mortality risk in the various study populations. For a range of reasons, endotoxemia can no longer be considered as a single entity. There are old clinical trials which warrant a re-appraisal in light of these recent advances in the understanding of the structure-function relationship of endotoxin. Fundamentally however, the disconnect not only remains, it has enlarged. Full article
(This article belongs to the Special Issue Toxin-Antibody Interactions)
Show Figures

Figure 1

Figure 1
<p>The location of the lipopolysaccharide (endotoxin) molecule in the cell wall of Gram negative bacteria.</p>
Full article ">Figure 2
<p>The components of the lipopolysaccharide (endotoxin) molecule.</p>
Full article ">Figure 3
<p>Simplified diagram of TLR4-MD-2 receptor complex dimerization upon ligation of hexa-acyl lipid A. See text for description. Copyright <sup>©</sup> 2013 Maeshima and Fernandez. From reference [<a href="#B13-toxins-05-02589" class="html-bibr">13</a>], an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited.</p>
Full article ">Figure 4
<p>L’Abbé plots of study specific mortality rates from 35 studies. Each figure shows mortality rates for studies undertaken in an ICU (triangles) or non-ICU (circles) setting with symbols proportional to group size with the line of no difference (y = x; dotted line) shown for visual reference purposes. Shown are (<b>a</b>) Groups 1 (endotoxemia and GN bacteremia detected) <span class="html-italic">versus</span> groups 4 (neither detected); (<b>b</b>) Groups 2 (GN bacteremia alone) <span class="html-italic">versus</span> groups 4 (neither detected); and (<b>c</b>) Groups 3 (endotoxemia alone) <span class="html-italic">versus</span> groups 4 (neither detected). GN, gram negative. From [<a href="#B77-toxins-05-02589" class="html-bibr">77</a>] <sup>©</sup> 2012 Hurley <span class="html-italic">et al</span>.; licensee BioMed Central Ltd., an open access article distributed under the terms of the Creative Commons Attribution License.</p>
Full article ">
1283 KiB  
Article
Expression of VEGF and Flk-1 and Flt-1 Receptors during Blood-Brain Barrier (BBB) Impairment Following Phoneutria nigriventer Spider Venom Exposure
by Monique C. P. Mendonça, Edilene S. Soares, Leila M. Stávale, Catarina Rapôso, Andressa Coope, Evanguedes Kalapothakis and Maria Alice Da Cruz-Höfling
Toxins 2013, 5(12), 2572-2588; https://doi.org/10.3390/toxins5122572 - 18 Dec 2013
Cited by 15 | Viewed by 7570
Abstract
Apart from its angiogenic and vascular permeation activity, the vascular endothelial growth factor (VEGF) has been also reported as a potent neuronal protector. Newborn rats with low VEGF levels develop neuron degeneration, while high levels induce protective mechanisms in several neuropathological conditions. Phoneutria [...] Read more.
Apart from its angiogenic and vascular permeation activity, the vascular endothelial growth factor (VEGF) has been also reported as a potent neuronal protector. Newborn rats with low VEGF levels develop neuron degeneration, while high levels induce protective mechanisms in several neuropathological conditions. Phoneutria nigriventer spider venom (PNV) disrupts the blood-brain barrier (BBB) and causes neuroinflammation in central neurons along with excitotoxic signals in rats and humans. All these changes are transient. Herein, we examined the expression of VEGF and its receptors, Flt-1 and Flk-1 in the hippocampal neurons following envenomation by PNV. Adult and neonatal rats were evaluated at time limits of 2, 5 and 24 h. Additionally, BBB integrity was assessed by measuring the expression of occludin, ?-catenin and laminin and neuron viability was evaluated by NeuN expression. VEGF, Flt-1 and Flk-1 levels increased in PNV-administered rats, concurrently with respective mRNAs. Flt-1 and Flk-1 immunolabeling was nuclear in neurons of hippocampal regions, instead of the VEGF membrane-bound typical location. These changes occurred simultaneously with the transient decreases in BBB-associated proteins and NeuN positivity. Adult rats showed more prominent expressional increases of the VEGF/Flt-1/Flk-1 system and earlier recovery of BBB-related proteins than neonates. We conclude that the reactive expressional changes seen here suggest that VEGF and receptors could have a role in the excitotoxic mechanism of PNV and that such role would be less efficient in neonate rats. Full article
Show Figures

Figure 1

Figure 1
<p>Immunoblots of occludin (<b>A</b>), β-catenin (<b>B</b>) and laminin (<b>C</b>). <span class="html-italic">Phoneutria nigriventer</span> (PNV) intra-peritoneal (i.p) injection induced significant decreases of all three proteins at 2 h for adults, whereas at 5 h for neonates. <b>*</b> <span class="html-italic">p</span> ≤ 0.05 and <b>***</b> <span class="html-italic">p</span> ≤ 0.001 denote significant decreases relative to controls; <sup>##</sup> <span class="html-italic">p</span> ≤ 0.01 and <sup>###</sup> <span class="html-italic">p</span> ≤ 0.001 indicate PNV-treated neonates with higher increase in laminin expression than their adult counterpart at 2 and 5 h. Student <span class="html-italic">t</span>-test; data are shown as means ± SEM.</p>
Full article ">Figure 2
<p>CA1 subfield of 8–10-week-old rats: composite photomicrographs of hippocampal coronal sections stained for localization of anti-VEGF, anti-Flt-1 and anti-Flk-1 and using the immunoperoxidase technique. (<b>A</b>,<b>C</b>,<b>E</b>) are sections from controls (saline-treated) and (<b>B</b>,<b>D</b>,<b>F</b>) are from PNV-treated adult rats 5 h after i.p. injection. PNV increased the immunoreactivity of VEGF, Flt-1 and Flk-1. Py = stratum pyramidale; Or = stratum oriens; Rad = stratum radiatum; <b>*</b> = microvessels with perivascular edema. Scale Bars = 25 µm.</p>
Full article ">Figure 3
<p>Western blot signals were densitometrically quantified and normalized to an internal standard (β-actin). VEGF (<b>A</b>), Flt-1 (<b>B</b>) and Flk-1 (<b>C</b>) expressions in PNV-treated samples (1.7 mg/kg) relative to control (CTR); <b>*</b> <span class="html-italic">p</span> ≤ 0.05 and <b>***</b> <span class="html-italic">p</span> ≤ 0.001 indicate significant difference relative to respective controls; <sup>#</sup> <span class="html-italic">p</span> ≤ 0.05 and <sup>##</sup> <span class="html-italic">p</span> ≤ 0.01 denote significant age-related differences between control (CTR) or PNV-treated groups at corresponding time-point. Student <span class="html-italic">t-</span>test; data were shown as means ± SEM.</p>
Full article ">Figure 4
<p>Quantitative real-time polymerase chain reaction (PCR) analysis quantified and normalized to endogen control (GAPDH). VEGF (<b>A</b>), Flt-1 (<b>B</b>) and Flk-1 (<b>C</b>) mRNAs expression at time-points after PNV (1.7 mg/kg) or 0.9% saline peritoneal injection. <b>*</b> <span class="html-italic">p</span> ≤ 0.05 and <b>**</b> <span class="html-italic">p</span> ≤ 0.01 indicate significant difference relative to respective controls; <sup>#</sup> <span class="html-italic">p</span> ≤ 0.05, <sup>##</sup> <span class="html-italic">p</span> ≤ 0.01 and <sup>###</sup> <span class="html-italic">p</span> ≤ 0.001, denote significant age-related differences between control (CTR) or PNV-treated groups at corresponding time-point. Student <span class="html-italic">t-</span>test; data were shown as means ± SEM.</p>
Full article ">Figure 5
<p>NeuN labeling in the CA2 subfield of 8–10-week-old rats 5 hafter i.p. injection of saline solution (<b>A</b>) or PNV (<b>B</b>). Py = stratum pyramidale; Or = stratum oriens; Rad = stratum radiatum; <b>*</b> = microvessels with perivascular edema. (<b>C</b>) Percentage of pixel density of NeuN-labeled neurons in different time points. (<b>D</b>) Immunoblots of NeuN in the hippocampus of i.p.-injected saline or PNV rats at 2, 5 and 24 h. <b>*</b> <span class="html-italic">p</span> ≤ 0.05 and <b>**</b> <span class="html-italic">p</span> ≤ 0.01 denote significant decrease of the nuclear marker relative to respective controls; <sup>#</sup> <span class="html-italic">p</span> ≤ 0.05, <sup>##</sup> <span class="html-italic">p</span> ≤ 0.01 and <sup>###</sup> <span class="html-italic">p</span> ≤ 0.001) denote significant difference in NeuN expression between control (CTR) or PNV-treated groups at the corresponding time-point. Student <span class="html-italic">t</span>-test; data were shown as means ± SEM. Scale Bars = 25 µm.</p>
Full article ">
10055 KiB  
Review
Secreted Phospholipases A2 of Snake Venoms: Effects on the Peripheral Neuromuscular System with Comments on the Role of Phospholipases A2 in Disorders of the CNS and Their Uses in Industry
by John B. Harris and Tracey Scott-Davey
Toxins 2013, 5(12), 2533-2571; https://doi.org/10.3390/toxins5122533 - 17 Dec 2013
Cited by 120 | Viewed by 17280
Abstract
Neuro- and myotoxicological signs and symptoms are significant clinical features of envenoming snakebites in many parts of the world. The toxins primarily responsible for the neuro and myotoxicity fall into one of two categories—those that bind to and block the post-synaptic acetylcholine receptors [...] Read more.
Neuro- and myotoxicological signs and symptoms are significant clinical features of envenoming snakebites in many parts of the world. The toxins primarily responsible for the neuro and myotoxicity fall into one of two categories—those that bind to and block the post-synaptic acetylcholine receptors (AChR) at the neuromuscular junction and neurotoxic phospholipases A2 (PLAs) that bind to and hydrolyse membrane phospholipids of the motor nerve terminal (and, in most cases, the plasma membrane of skeletal muscle) to cause degeneration of the nerve terminal and skeletal muscle. This review provides an introduction to the biochemical properties of secreted sPLA2s in the venoms of many dangerous snakes and a detailed discussion of their role in the initiation of the neurologically important consequences of snakebite. The rationale behind the experimental studies on the pharmacology and toxicology of the venoms and isolated PLAs in the venoms is discussed, with particular reference to the way these studies allow one to understand the biological basis of the clinical syndrome. The review also introduces the involvement of PLAs in inflammatory and degenerative disorders of the central nervous system (CNS) and their commercial use in the food industry. It concludes with an introduction to the problems associated with the use of antivenoms in the treatment of neuro-myotoxic snakebite and the search for alternative treatments. Full article
(This article belongs to the Special Issue Neurotoxins: Health Threats and Biological Tools)
Show Figures

Figure 1

Figure 1
<p>Glycerophospholipid structure and the site of action of phospholipases. The phospholipid molecule consists of a glycerol-3-phosphate (<b>blue</b>) esterified at positions sn-1 and sn-2 to non-polar fatty acids. Its phosphoryl group is esterified to a polar head group (x). Phospholipases A<sub>1</sub> cleave the ester bond at the sn-1 position. Phospholipases A<sub>2</sub> cleave the ester bond at the sn-2 position. Phospholipases B cleave the ester bonds at both sn-1 and sn-2 positions. Phospholipases C cleave the glycerophosphate bond and phospholipases D remove the polar head group. From The AOCS Lipid Library (<a href="http://lipidlibrary.aocs.org/animbio/phospholipases/index.htm" target="_blank">http://lipidlibrary.aocs.org/animbio/phospholipases/index.htm</a>).</p>
Full article ">Figure 2
<p>Snakes frequently involved in major neuro-myotoxic envenoming in humans. (<b>A</b>) the Australian Tiger snake, <span class="html-italic">Notechis scutatus</span> and (<b>B</b>) the South American rattlesnake, <span class="html-italic">Crotalus durissus terrificus</span>, both cause neurotoxicity and rhabdomyolysis; (<b>C</b>) the Taiwanese Multi-banded krait, <span class="html-italic">Bungarus multicinctus</span> causes severe neurotoxicity but no myotoxicity; (<b>D</b>) the Beaked sea snake, <span class="html-italic">Enhydrina schistosa</span>, causes severe myotoxicity but rarely neurotoxicity in human subjects.</p>
Full article ">Figure 3
<p>(<b>A</b>). A group 1A phospholipase A<sub>2</sub> with phospholipid substrate modeled in the active site. The active site residues His-48 and Asp-99 and the bound Ca<sup>2+</sup> is shown in purple. Ca<sup>2+</sup> is bound by Asp-49 as well as the carbonyl oxygens of Tyr-28, Gly-30 and Gly-32. Aromatic residues are shown in white; (<b>B</b>). Model of the lipid binding of the group 1A PLA<sub>2</sub> is shown with residues on the interfacial binding surface Tyr-3, Trp-19, Trp-61 and Phe-64 shown in stick form. From Burke and Dennis 2008 [<a href="#B1-toxins-05-02533" class="html-bibr">1</a>].</p>
Full article ">Figure 4
<p>Victim of an envenoming bite by an unidentified snake on admission at a tertiary referral hospital in Chittagong, Bangladesh. Note multiple tight ligatures applied to the arm.</p>
Full article ">Figure 5
<p>Incisions applied to the hand and lower leg respectively in two victims of envenoming bites by unidentified snakes in Chittagong, Bangladesh.</p>
Full article ">Figure 6
<p>Localised necrosis following an envenoming bite to the foot by the viperid Fer de Lance, (<span class="html-italic">Bothrops asper</span>).</p>
Full article ">Figure 7
<p>(<b>A</b>) Young boy with severe neurotoxic signs following a bite by a cobra (species unknown) in Bangladesh; (<b>B</b>) Full recovery 24 h later following treatment with antivenom.</p>
Full article ">Figure 8
<p>Wrist drop and foot drop, respectively, many months after the apparently successful treatment of victims of neurotoxic snake bites in Chittagong, Bangladesh.</p>
Full article ">Figure 9
<p>Severe neurotoxicity and rhabdomyolysis (note the black urine) following an envenoming bite by a greater black krait, <span class="html-italic">Bungarus niger</span> in Bangladesh. The patient did not recover.</p>
Full article ">Figure 10
<p>Ptosis and rhabdomyolysis (note the black urine) following an envenoming bite by South American rattlesnake (<span class="html-italic">Crotalus durissus</span>) in Brazil.</p>
Full article ">Figure 11
<p>TEM Images of motor nerve terminal boutons on muscle fibres of the rat 12–24 h after the inoculation of notexin, a PLA<sub>2</sub> toxin from the venom of the Australian tiger snake, <span class="html-italic">Notechis scutatus</span>. (<b>A</b>) Control bouton on a muscle fibre not exposed to any toxin. Note the folds of the postsynaptic membrane (<b>Arrows</b>); (<b>B</b>–<b>E</b>) Note the widespread loss of synaptic vesicles from the boutons and the swollen mitochondria (<b>small arrows</b>). Note also the well preserved junction folds of the neuromuscular junctions (<b>large arrows</b> in <b>C</b>). Combined damage to both bouton and muscle fibre is shown in <b>D</b>: a <b>star</b> marks the collapsed muscle fibre but note the preservation of the junctional folds at the neuromuscular junction.</p>
Full article ">Figure 12
<p>A terminal bouton in advanced stages of degeneration. Note the lesions in the plasma membrane (<b>arrows</b>) and the damaged mitochondria (<b>stars</b>).</p>
Full article ">Figure 13
<p>Longitudinal sections of rat soleus muscles 24 h after the inoculation, <span class="html-italic">in vivo</span>, of the venom of the Greater black krait, <span class="html-italic">Bungarus niger</span>. Sections were labelled with TRITC-conjugated α-Bungarotoxin to label junctional ACh receptors (<b>red</b>) and FITC conjugated Ab to neurofilament protein to label motor axons (<b>green</b>). (<b>A</b>) control image; (<b>B</b>–<b>E</b>) Progressive breakdown of the terminal innervation at the neuromuscular junction. Note the preservation of the junctional ACh receptors (From Faiz <span class="html-italic">et al</span>. 2010 [<a href="#B68-toxins-05-02533" class="html-bibr">68</a>]). Reproduced with permission from Publisher.</p>
Full article ">Figure 14
<p>(<b>A</b>) Longitudinal section of murine muscle labelled with ammodytoxin A, an sPLA<sub>2</sub> from the venom of the long-nosed viper, <span class="html-italic">Vipera ammodytes</span>, conjugated with Alexa<sup>546</sup> (<b>red</b>) and counter-labelled with FITC-conjugated α-Bungarotoxin to label junctional ACh receptors (<b>green</b>) (<b>B</b>) a laser scan of red and green channels to demonstrate localisation of sPLA<sub>2</sub> to the neuromuscular junction. (From Logonder <span class="html-italic">et al</span>. 2008 [<a href="#B85-toxins-05-02533" class="html-bibr">85</a>]). Reproduced with permission from the Publisher.</p>
Full article ">Figure 15
<p>The density of synaptic vesicles in terminal boutons of rat neuromuscular junctions. Vesicle density was unchanged in muscles incubated <span class="html-italic">in vitro</span> with either botulinum toxin C or conotoxin ω-MVIIC. Incubation with β-bungarotoxin, an SPLA<sub>2</sub> toxin from the venom of <span class="html-italic">Bungarus multicinctus</span>, caused a significant fall in vesicle density. The fall was largely or completely prevented in muscles pre-treated with either botulinum toxin C or conotoxin ω-MVIIC before exposure to β-bungarotoxin. (From Prasarnpun <span class="html-italic">et al</span>. 2004 [<a href="#B76-toxins-05-02533" class="html-bibr">76</a>]). Reproduced with permission from the Publisher.</p>
Full article ">Figure 16
<p>TEM images of terminal boutons on murine muscle fibres previously exposed to a gold-labelled sPLA<sub>2</sub> from the venom of the horned viper (<span class="html-italic">Vipera ammodytes ammodytes</span>). The control bouton (<b>A</b>) is not decorated; Bouton <b>B</b> shows particles within the synaptic cleft and folds. Bouton <b>C</b> shows particles in the synaptic cleft and the bouton itself. Enlarged images (<b>D</b>–<b>I</b>) show particles associated with vesicle–like structures within the bouton or with mitochondria (<b>open arrows</b>). The association between label and vesicle-like structures suggest that uptake might occur during the recycling of synaptic vesicles and endocytosis. (Modified from Logonder <span class="html-italic">et al</span>. 2009 [<a href="#B94-toxins-05-02533" class="html-bibr">94</a>]). Reproduced with permission from the Publisher.</p>
Full article ">Figure 17
<p>A cluster of six individual end-plates (labelled with FITC-conjugated α-bungarotoxin) innervated by the clustered intramuscular branching of a single motor axon (labelled with TRITC-conjugated anti-neurofilament Ab.</p>
Full article ">Figure 18
<p>(<b>A</b>–<b>C</b>) Transverse sections of soleus muscles stained with haematoxylin and eosin (H&amp;E). (<b>A</b>) control; (<b>B</b>,<b>C</b>) Three and 24 h respectively after exposure, <span class="html-italic">in vivo</span>, to notexin, an sPLA<sub>2</sub> from the venom of the Australian tiger snake, <span class="html-italic">Notechis scutatus</span>. Note the early inflammatory response and the later degeneration of the muscle fibres; (<b>D</b>) Longitudinal section at 24 h stained with procion yellow. This dye is excluded from cells with an intact plasma membrane. Note that it has entered the muscle fibres and stained the congealed, hyper-contracted myofilaments.</p>
Full article ">Figure 19
<p>TEM of a longitudinal section of a rat soleus muscle fibre labelled with a gold-conjugated Ab against notexin, an sPLA<sub>2</sub> from the venom of the Australian tiger snake, <span class="html-italic">Notechis scutatus</span>, three hrs after exposure <span class="html-italic">in vivo</span> to the toxin. Arrows indicate individual silver-enhanced gold particles. (From Dixon and Harris 1996 [<a href="#B109-toxins-05-02533" class="html-bibr">109</a>]). Reproduced with permission from the Publisher.</p>
Full article ">Figure 20
<p>The relative rates of loss of desmin and myosin from muscles at various times after the inoculation of the venom of <span class="html-italic">Notechis scutatus</span>. (From Harris <span class="html-italic">et al</span>. 2003 [<a href="#B114-toxins-05-02533" class="html-bibr">114</a>]). Reproduced with permission from the Publisher.</p>
Full article ">Figure 21
<p>(<b>A</b>–<b>C</b>) Transverse sections of soleus muscles stained with H&amp;E. A. control. B, C. Four and 28 days respectively after exposure, <span class="html-italic">in vivo</span>, to notexin, an sPLA<sub>2</sub> from the venom of the Australian tiger snake, <span class="html-italic">Notechis scutatus</span>. Note the rapid growth of the muscle fibres and the continuing presence of centrally located myonuclei; (<b>D</b>) As above 28 days after exposure <span class="html-italic">in vivo</span> to the venom of the Fer de Lance, <span class="html-italic">Bothrops asper</span>, a viperid snake that causes extensive soft tissue necrosis (see <a href="#toxins-05-02533-f005" class="html-fig">Figure 5</a>). Note the immature appearance of the regenerating muscle fibres and the extensive infiltration of connective tissue.</p>
Full article ">
321 KiB  
Article
Analysis of Deoxynivalenol and Deoxynivalenol-3-glucoside in Hard Red Spring Wheat Inoculated with Fusarium Graminearum
by Maribel Ovando-Martínez, Bahri Ozsisli, James Anderson, Kristin Whitney, Jae-Bom Ohm and Senay Simsek
Toxins 2013, 5(12), 2522-2532; https://doi.org/10.3390/toxins5122522 - 17 Dec 2013
Cited by 39 | Viewed by 7282
Abstract
Deoxynivalenol (DON) is a mycotoxin affecting wheat quality. The formation of the “masked” mycotoxin deoxinyvalenol-3-glucoside (D3G) results from a defense mechanism the plant uses for detoxification. Both mycotoxins are important from a food safety point of view. The aim of this work was [...] Read more.
Deoxynivalenol (DON) is a mycotoxin affecting wheat quality. The formation of the “masked” mycotoxin deoxinyvalenol-3-glucoside (D3G) results from a defense mechanism the plant uses for detoxification. Both mycotoxins are important from a food safety point of view. The aim of this work was to analyze DON and D3G content in inoculated near-isogenic wheat lines grown at two locations in Minnesota, USA during three different years. Regression analysis showed positive correlation between DON content measured with LC and GC among wheat lines, locality and year. The relationship between DON and D3G showed a linear increase until a certain point, after which the DON content and the D3G increased. Wheat lines having higher susceptibility to Fusarium showed the opposite trend. ANOVA demonstrated that the line and location have a greater effect on variation of DON and D3G than do their interaction among years. The most important factor affecting DON and D3G was the growing location. In conclusion, the year, environmental conditions and location have an effect on the D3G/DON ratio in response to Fusarium infection. Full article
(This article belongs to the Special Issue Recent Advances and Perspectives in Deoxynivalenol Research)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Correlation between liquid chromatography deoxynivalenol (LC-DON) and deoxynivalenol-3-glucoside (D3G) values (combined 2008, 2009 and 2010). *** Significantly different from 1 at <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">
281 KiB  
Article
Phormidium autumnale Growth and Anatoxin-a Production under Iron and Copper Stress
by Francine M. J. Harland, Susanna A. Wood, Elena Moltchanova, Wendy M. Williamson and Sally Gaw
Toxins 2013, 5(12), 2504-2521; https://doi.org/10.3390/toxins5122504 - 16 Dec 2013
Cited by 31 | Viewed by 9265
Abstract
Studies on planktonic cyanobacteria have shown variability in cyanotoxin production, in response to changes in growth phase and environmental factors. Few studies have investigated cyanotoxin regulation in benthic mat-forming species, despite increasing reports on poisoning events caused by ingestion of these organisms. In [...] Read more.
Studies on planktonic cyanobacteria have shown variability in cyanotoxin production, in response to changes in growth phase and environmental factors. Few studies have investigated cyanotoxin regulation in benthic mat-forming species, despite increasing reports on poisoning events caused by ingestion of these organisms. In this study, a method was developed to investigate changes in cyanotoxin quota in liquid cultures of benthic mat-forming cyanobacteria. Iron and copper are important in cellular processes and are well known to affect growth and selected metabolite production in cyanobacteria and algae. The effect of iron (40–4000 ?g L?1) and copper (2.5–250 ?g L?1) on growth and anatoxin-a quota in Phormidium autumnale was investigated in batch culture. These concentrations were chosen to span those found in freshwater, as well as those previously reported to be toxic to cyanobacteria. Anatoxin-a concentrations varied throughout the growth curve, with a maximum quota of between 0.49 and 0.55 pg cell?1 measured within the first two weeks of growth. Growth rates were significantly affected by copper and iron concentrations (P < 0.0001); however, no statistically significant difference between anatoxin-a quota maxima was observed. When the iron concentrations were 800 and 4000 ?g L?1, the P. autumnale cultures did not firmly attach to the substratum. At 250 ?g L?1 copper or either 40 or 4000 ?g L?1 iron, growth was suppressed. Full article
(This article belongs to the Collection Marine and Freshwater Toxins)
Show Figures

Figure 1

Figure 1
<p>Mean metal concentrations in MLA with 95% confidence intervals measured in <span class="html-italic">Phormidium autumnale</span> (CYN52) growth experiments: (<b>a</b>) Iron <span class="html-fig-inline" id="toxins-05-02504-i001"> <img alt="Toxins 05 02504 i001" src="/toxins/toxins-05-02504/article_deploy/html/images/toxins-05-02504-i001.png"/></span> control, ■ treatment (MLA<sub>2×Fe</sub>); (<b>b</b>) Copper <span class="html-fig-inline" id="toxins-05-02504-i001"> <img alt="Toxins 05 02504 i001" src="/toxins/toxins-05-02504/article_deploy/html/images/toxins-05-02504-i001.png"/></span> control, ■ treatment (MLA<sub>2×Fe</sub>). (<span class="html-italic">n</span> = 3 for cultures, <span class="html-italic">n</span> = 2+ for controls).</p>
Full article ">Figure 2
<p>Growth profile for <span class="html-italic">Phormidium autumnale</span> (CYN52) under (<b>a</b>) iron (Fe) and (<b>b</b>) copper (Cu) regimes over 49 days. Growth is recorded as mean number of cells per 30 mL culture with 95% confidence intervals (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 3
<p>Intracellular anatoxin-a in <span class="html-italic">Phormidium autumnale</span> (CYN52) under (<b>a</b>) iron (Fe) and (<b>b</b>) copper (Cu) regimes. Anatoxin-a quota are recorded as mean concentrations with 95% confidence intervals (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 4
<p>Extracellular anatoxin-a detected in <span class="html-italic">Phormidium autumnale</span> (CYN52) growth experiment under standard MLA<sub>1×Fe,1×Cu</sub>. Extracellular anatoxin-a is recorded as mean concentration with 95% confidence intervals (<span class="html-italic">n</span> = 3); nd, not detected.</p>
Full article ">Figure 5
<p>Percentage of extracellular anatoxin-a from total intra- and extracellular anatoxin-a detected for each treatment (Fe = iron, Cu = copper) during the late exponential and stationary phase. 95% confidence intervals are included; <span class="html-fig-inline" id="toxins-05-02504-i002"> <img alt="Toxins 05 02504 i002" src="/toxins/toxins-05-02504/article_deploy/html/images/toxins-05-02504-i002.png"/></span> statistically significant concentrations per day; nd, not detected.</p>
Full article ">
1909 KiB  
Article
A Proteomics and Transcriptomics Investigation of the Venom from the Barychelid Spider Trittame loki (Brush-Foot Trapdoor)
by Eivind A. B. Undheim, Kartik Sunagar, Volker Herzig, Laurence Kely, Dolyce H. W. Low, Timothy N. W. Jackson, Alun Jones, Nyoman Kurniawan, Glenn F. King, Syed A. Ali, Agostino Antunes, Tim Ruder and Bryan G. Fry
Toxins 2013, 5(12), 2488-2503; https://doi.org/10.3390/toxins5122488 - 13 Dec 2013
Cited by 61 | Viewed by 11324
Abstract
Although known for their potent venom and ability to prey upon both invertebrate and vertebrate species, the Barychelidae spider family has been entirely neglected by toxinologists. In striking contrast, the sister family Theraphosidae (commonly known as tarantulas), which last shared a most recent [...] Read more.
Although known for their potent venom and ability to prey upon both invertebrate and vertebrate species, the Barychelidae spider family has been entirely neglected by toxinologists. In striking contrast, the sister family Theraphosidae (commonly known as tarantulas), which last shared a most recent common ancestor with Barychelidae over 200 million years ago, has received much attention, accounting for 25% of all the described spider toxins while representing only 2% of all spider species. In this study, we evaluated for the first time the venom arsenal of a barychelid spider, Trittame loki, using transcriptomic, proteomic, and bioinformatic methods. The venom was revealed to be dominated by extremely diverse inhibitor cystine knot (ICK)/knottin peptides, accounting for 42 of the 46 full-length toxin precursors recovered in the transcriptomic sequencing. In addition to documenting differential rates of evolution adopted by different ICK/knottin toxin lineages, we discovered homologues with completely novel cysteine skeletal architecture. Moreover, acetylcholinesterase and neprilysin were revealed for the first time as part of the spider-venom arsenal and CAP (CRiSP/Allergen/PR-1) were identified for the first time in mygalomorph spider venoms. These results not only highlight the extent of venom diversification in this neglected ancient spider lineage, but also reinforce the idea that unique venomous lineages are rich pools of novel biomolecules that may have significant applied uses as therapeutics and/or insecticides. Full article
(This article belongs to the Collection Evolution of Venom Systems)
Show Figures

Figure 1

Figure 1
<p>Magnetic resonance imaging of <span class="html-italic">Trittame loki</span> venom glands.</p>
Full article ">Figure 2
<p>Phylogenetic reconstruction of <span class="html-italic">Trittame loki</span> and related inhibitor cystine knot (ICK)/knottin peptide toxins, conserved ancestral cysteines are shown in black, newly evolved cysteines are in red. Sequences obtained in this study are in green. Signal peptides are shown in lowercase.</p>
Full article ">Figure 3
<p>Sequence alignment of spider venom colipase venom peptides: (1) <span class="html-italic">Trittame loki</span> COLIPASE-1; (2) D2Y2E5 <span class="html-italic">Haplopelma hainanum</span>; (3) Q5D233 <span class="html-italic">Hadronyche infensa</span>; (4) Q5D231 <span class="html-italic">Hadronyche</span> sp. (strain 20); (5) Q5D232 <span class="html-italic">Hadronyche</span> sp. (strain 20); (6) B1P1J0 <span class="html-italic">Chilobrachys jingzhao</span>; and (7) B1P1J2 <span class="html-italic">Chilobrachys jingzhao.</span> Signal peptides are shown in lowercase.</p>
Full article ">Figure 4
<p>Sequence alignment of spider venom CAP (CRiSP/Allergen/PR-1) venom peptides: (1) <span class="html-italic">Trittame loki</span> CAP-1; and (2) A9QQ26 <span class="html-italic">Lycosa singoriensis.</span> Signal peptides are shown in lowercase.</p>
Full article ">Figure 5
<p>Sequence alignment of spider venom kunitz venom peptides: (1) <span class="html-italic">Trittame loki</span> KUNITZ-1; and (2) E7D1N7 <span class="html-italic">Latrodectus hesperus.</span> Signal peptides are shown in lowercase.</p>
Full article ">Figure 6
<p>Sequence alignment of the <span class="html-italic">Trittame loki</span> venom acetylcholinesterase and the non-venom homologue P56161 <span class="html-italic">Anopheles stephensi.</span> Signal peptides are shown in lowercase.</p>
Full article ">Figure 7
<p>Sequence alignment of the <span class="html-italic">Trittame loki</span> venom neprilysin and the snake venom convergent neprilysin homologue T1E4Z0 <span class="html-italic">Crotalus horridus</span>. Signal peptides are shown in lowercase.</p>
Full article ">
5767 KiB  
Article
Evolution Stings: The Origin and Diversification of Scorpion Toxin Peptide Scaffolds
by Kartik Sunagar, Eivind A. B. Undheim, Angelo H. C. Chan, Ivan Koludarov, Sergio A. Muñoz-Gómez, Agostinho Antunes and Bryan G. Fry
Toxins 2013, 5(12), 2456-2487; https://doi.org/10.3390/toxins5122456 - 13 Dec 2013
Cited by 75 | Viewed by 14470
Abstract
The episodic nature of natural selection and the accumulation of extreme sequence divergence in venom-encoding genes over long periods of evolutionary time can obscure the signature of positive Darwinian selection. Recognition of the true biocomplexity is further hampered by the limited taxon selection, [...] Read more.
The episodic nature of natural selection and the accumulation of extreme sequence divergence in venom-encoding genes over long periods of evolutionary time can obscure the signature of positive Darwinian selection. Recognition of the true biocomplexity is further hampered by the limited taxon selection, with easy to obtain or medically important species typically being the subject of intense venom research, relative to the actual taxonomical diversity in nature. This holds true for scorpions, which are one of the most ancient terrestrial venomous animal lineages. The family Buthidae that includes all the medically significant species has been intensely investigated around the globe, while almost completely ignoring the remaining non-buthid families. Australian scorpion lineages, for instance, have been completely neglected, with only a single scorpion species (Urodacus yaschenkoi) having its venom transcriptome sequenced. Hence, the lack of venom composition and toxin sequence information from an entire continent’s worth of scorpions has impeded our understanding of the molecular evolution of scorpion venom. The molecular origin, phylogenetic relationships and evolutionary histories of most scorpion toxin scaffolds remain enigmatic. In this study, we have sequenced venom gland transcriptomes of a wide taxonomical diversity of scorpions from Australia, including buthid and non-buthid representatives. Using state-of-art molecular evolutionary analyses, we show that a majority of CS?/? toxin scaffolds have experienced episodic influence of positive selection, while most non-CS?/? linear toxins evolve under the extreme influence of negative selection. For the first time, we have unraveled the molecular origin of the major scorpion toxin scaffolds, such as scorpion venom single von Willebrand factor C-domain peptides (SV-SVC), inhibitor cystine knot (ICK), disulphide-directed beta-hairpin (DDH), bradykinin potentiating peptides (BPP), linear non-disulphide bridged peptides and antimicrobial peptides (AMP). We have thus demonstrated that even neglected lineages of scorpions are a rich pool of novel biochemical components, which have evolved over millions of years to target specific ion channels in prey animals, and as a result, possess tremendous implications in therapeutics. Full article
(This article belongs to the Collection Evolution of Venom Systems)
Show Figures

Figure 1

Figure 1
<p>Bayesian phylogenetic reconstruction of the Na<sub>V</sub>-CSα/β clade<b>.</b> Outgroups were the K<sub>V</sub>-CSα/β Q0GY40 <span class="html-italic">Hadrurus gertschi</span> and Q95NK7 <span class="html-italic">Mesobuthus martensi</span>. <b>*</b><span class="html-italic">Chaerilus tricostatus</span> contig sequence is from [<a href="#B71-toxins-05-02456" class="html-bibr">71</a>].</p>
Full article ">Figure 2
<p>The two alternate scenarios of the cysteine relationships between DDH and ICK peptides. Sequences presented: 1. B8QG00 <span class="html-italic">Hadrurus gertschi</span>; 2. P59868 <span class="html-italic">Pandinus imperator</span>; 3. B8XH22 <span class="html-italic">Buthus occitanus israel</span>; 4. P0DJL0 <span class="html-italic">Isometrus maculatus</span>; 5. P0C5F2 <span class="html-italic">Liocheles australasiae</span>; 6. F8W670 <span class="html-italic">Liocheles australasiae</span>; 7. GALI01000016 <span class="html-italic">Urodacus manicatus</span>; 8. C5J894 <span class="html-italic">Opisthacanthus cayaporum</span>; 9. GALI01000015 <span class="html-italic">Urodacus manicatus</span>; 10. P0DJ08 <span class="html-italic">Liocheles waigiensis</span>; 11. SmpIT2 <span class="html-italic">Scorpio maurus palmatus</span> [<a href="#B66-toxins-05-02456" class="html-bibr">66</a>] and 12. GALI01000017 <span class="html-italic">Urodacus manicatus</span>. ICK connectivity schematic image adopted from [<a href="#B63-toxins-05-02456" class="html-bibr">63</a>]. Alignment scenario 1 is that proposed previously [<a href="#B63-toxins-05-02456" class="html-bibr">63</a>,<a href="#B64-toxins-05-02456" class="html-bibr">64</a>,<a href="#B65-toxins-05-02456" class="html-bibr">65</a>] while alignment scenario 2 is the alternative proposed in this study to better reflect charge molecule distribution.</p>
Full article ">Figure 3
<p>Bayesian phylogenetic reconstruction of the SV-SVC, ICK and DDH clade. Outgroups were the non-toxin SVC peptides B4M772 <span class="html-italic">Drosophila virilis</span> and B4NQ53 <span class="html-italic">Drosophila willistoni</span>. <b>*</b> SmpIT2 <span class="html-italic">Scorpio maurus palmatus</span> is from [<a href="#B66-toxins-05-02456" class="html-bibr">66</a>]. Alignment scenario 1 is that proposed previously [<a href="#B63-toxins-05-02456" class="html-bibr">63</a>,<a href="#B64-toxins-05-02456" class="html-bibr">64</a>,<a href="#B65-toxins-05-02456" class="html-bibr">65</a>] while alignment scenario 2 is the alternative proposed in this study to better reflect charge molecule distribution.</p>
Full article ">Figure 4
<p>Sequence alignment of cytotoxic linear peptides: (1). GALK01000016 <span class="html-italic">Isometroides vescus</span>; (2). GALK01000016 <span class="html-italic">Isometroides vescus</span>; (3). GALL01000023 <span class="html-italic">Lychas buchari</span>; (4). D9U2B7 <span class="html-italic">Lychas mucronatus</span>; (5). Q9Y0X4 <span class="html-italic">Mesobuthus martensii</span>; (6). C9X4J0 <span class="html-italic">Tityus discrepans</span>; (7). P0CF38 <span class="html-italic">Isometrus maculatus</span>; (8). P83312 <span class="html-italic">Parabuthus schlechteri</span>; (9). Q9GQW4 <span class="html-italic">Mesobuthus martensii</span>; (10). B8XH50 <span class="html-italic">Buthus occitanus israelii</span>; (11). I0DEB4 <span class="html-italic">Vaejovis mexicanus smithii</span>; (12). GALH01000010 <span class="html-italic">Cercophonius squama</span>; (13). <span class="html-italic">P0C8W1 Hadrurus gertschi</span>; (14). C5J886 <span class="html-italic">Opisthacanthus cayaporum</span>; (15). P0DJ03 <span class="html-italic">Heterometrus petersii</span>; (16). L0GCV8 <span class="html-italic">Urodacus yaschenkoi</span>; (17). P0DJO3 <span class="html-italic">Scorpiops tibetanus</span>; (18). GALH01000009 <span class="html-italic">Cercophonius squama</span>; (19). GALI01000003 <span class="html-italic">Urodacus manicatus</span>; (20). GALI01000004 <span class="html-italic">Urodacus manicatus</span>; (21). GALI01000007 <span class="html-italic">Urodacus manicatus</span>; (22). GALI01000005 <span class="html-italic">Urodacus manicatus</span>; (23). GALH01000008 <span class="html-italic">Cercophonius squama</span>; (24). GALI01000006 <span class="html-italic">Urodacus manicatus</span>; (25). L0GCI6 <span class="html-italic">Urodacus yaschenkoi</span>; (26). H2CYR5 <span class="html-italic">Pandinus cavimanus</span>; (27). G8YYA6 <span class="html-italic">Androctonus amoreuxi</span>; (28). B9UIY3 <span class="html-italic">Lychas mucronatus</span>; (29). GALL01000021 <span class="html-italic">Lychas buchari</span>; (30). GALK01000015 <span class="html-italic">Isometroides vescus</span>; (31). Q5G8B3 <span class="html-italic">Tityus costatus</span>; (32). E4VP60 <span class="html-italic">Mesobuthus eupeus</span>; (33). Q5G8B5 <span class="html-italic">Tityus costatus</span>; (34). D9U2B8 <span class="html-italic">Lychas mucronatus</span>; (35). C7B247 <span class="html-italic">Isometrus maculatus</span>; (36). G1FE62 <span class="html-italic">Chaerilus tricostatus</span>; (37). GALL01000022 <span class="html-italic">Lychas buchari.</span> Signal peptide and C-terminal cleaved propeptides are shown in lowercase. BPP domain shown in black and the cytotoxic posttranslationally processed peptide is highlighted in gray. ‘&gt;’ indicates incomplete sequence.</p>
Full article ">Figure 5
<p>Mid-point rooted Bayesian phylogenetic reconstruction of the cytotoxic linear peptides. * <span class="html-italic">Chaerilus tricostatus</span> and <span class="html-italic">C. tryznai</span> contig sequences are from [<a href="#B71-toxins-05-02456" class="html-bibr">71</a>].</p>
Full article ">Figure 6
<p>Molecular evolution of scorpion toxins. Three dimensional homology models of various scorpion CSα/β and non-CSα/β toxins, depicting the locations of positively selected sites are presented. Site-model 8 computed omega and the total number of positively selected sites (PS) detected by its Bayes Empirical Bayes (BEB) approach (<span class="html-italic">PP</span> ≥ 0.95) are indicated, along with the number of episodically diversifying sites (Epi) detected by MEME (at 0.05 significance). PDB codes used for modelling are: α-Na<sub>V</sub>-CSα/β: 1DJT; β-Na<sub>V</sub>-CSα/β: 2I61; Cl<sub>V</sub>-CSα/β: 1SIS; DDH: 2KYJ; ICK: 1IE6; short-K<sub>V</sub>-CSα/β: 1PVZ and SVC: 1U5M).</p>
Full article ">Figure 7
<p>Surface accessibility of hypermutable sites. A plot of amino acid positions (x-axis) against accessible surface area (ASA) ratio (y-axis) indicating the locations of amino acids (exposed or buried) in the crystal structure of various scorpion toxins is presented. Positively selected residues are presented as large dots, while the remaining sites are presented as small dots in the plot. Residues with an ASA ratio greater than 50% are considered to be exposed, while those with an ASA ratio less than 20% are considered to be buried to the surrounding medium (ASA of 21%–39%: cannot be assigned to buried/exposed class; ASA of 40%-50% are likely to have exposed side chains). Three dimensional homology models of various scorpion toxin types, depicting the locations of positively selected (PS) sites along with model 8 omega values and the number of exposed and buried positively selected sites are also presented. PDB codes used for modelling are: α-Na<sub>V</sub>-CSα/β: 1DJT; β-Na<sub>V</sub>-CSα/β: 2I61; Cl<sub>V</sub>-and CSα/β: 1SIS.</p>
Full article ">
938 KiB  
Article
Appearance of Planktothrix rubescens Bloom with [D-Asp3, Mdha7]MC–RR in Gravel Pit Pond of a Shallow Lake-Dominated Area
by Gábor Vasas, Oszkár Farkas, Gábor Borics, Tamás Felföldi, Gábor Sramkó, Gyula Batta, István Bácsi and Sándor Gonda
Toxins 2013, 5(12), 2434-2455; https://doi.org/10.3390/toxins5122434 - 12 Dec 2013
Cited by 27 | Viewed by 9344
Abstract
Blooms of toxic cyanobacteria are well-known phenomena in many regions of the world. Microcystin (MC), the most frequent cyanobacterial toxin, is produced by entirely different cyanobacteria, including unicellular, multicellular filamentous, heterocytic, and non-heterocytic bloom-forming species. Planktothrix is one of the most important MC-producing [...] Read more.
Blooms of toxic cyanobacteria are well-known phenomena in many regions of the world. Microcystin (MC), the most frequent cyanobacterial toxin, is produced by entirely different cyanobacteria, including unicellular, multicellular filamentous, heterocytic, and non-heterocytic bloom-forming species. Planktothrix is one of the most important MC-producing genera in temperate lakes. The reddish color of cyanobacterial blooms viewed in a gravel pit pond with the appearance of a dense 3 cm thick layer (biovolume: 28.4 mm3 L?1) was an unexpected observation in the shallow lake-dominated alluvial region of the Carpathian Basin. [d-Asp3, Mdha7]MC–RR was identified from the blooms sample by MALDI-TOF and NMR. Concentrations of [d-Asp3, Mdha7]MC–RR were measured by capillary electrophoresis to compare the microcystin content of the field samples and the isolated, laboratory-maintained P. rubescens strain. In analyzing the MC gene cluster of the isolated P. rubescens strain, a deletion in the spacer region between mcyE and mcyG and an insertion were located in the spacer region between mcyT and mcyD. The insertion elements were sequenced and partly identified. Although some invasive tropical cyanobacterial species have been given a great deal of attention in many recent studies, our results draw attention to the spread of the alpine organism P. rubescens as a MC-producing, bloom-forming species. Full article
(This article belongs to the Collection Marine and Freshwater Toxins)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Location of Kocka pond in Hungary, indicated by a filled circle; (<b>b</b>) The <span class="html-italic">Planktothrix rubescens</span> bloom in the gravel pit pond; and (<b>c</b>) a microscopic observation of <span class="html-italic">Planktothrix rubescens</span> trichomes from the pond.</p>
Full article ">Figure 2
<p>(<b>A</b>) Maximum likelihood trees showing the phylogenetic position of BGSD-500 based on the 16S rRNA gene and (<b>B</b>) the phycocyanin operon. In the case of the 16S rRNA gene, 1329 nt positions were involved in the analysis that was performed with the HKY + G substitution model, while for the construction of the <span class="html-italic">cpcBA</span>-IGS tree, 464 nt were used and the Kimura 2-parameter model was applied. Type strains of <span class="html-italic">Planktothrix</span> species according to Suda <span class="html-italic">et al.</span> [<a href="#B29-toxins-05-02434" class="html-bibr">29</a>] are marked with superscript T. <span class="html-italic">Arthrospira platensis</span> PCC 7345 was used as an outgroup in both phylogenetic analyses. Bootstrap values lower than 70 are not shown (based on 500 replicates).</p>
Full article ">Figure 3
<p>DEAE-52 chromatography and Blue-Green Sinapis Test of [<span class="html-small-caps">d</span>-Asp<sup>3</sup>, <span class="html-italic">M</span>dha<sup>7</sup>]MC–RR from <span class="html-italic">Planktothrix rubescens</span>. Absorbance at 239 nm (-○-); hypocotyl length of three-day-old mustard seedlings (-●-), gradient between 0 and 0.2 M NaCl in 5 mM Tris-HCl buffer (---).</p>
Full article ">Figure 4
<p>Chemical structure of the identified cyanobacterial heptapeptide [<span class="html-small-caps">d</span>-Asp<sup>3</sup>, <span class="html-italic">M</span>dha<sup>7</sup>]MC–RR.</p>
Full article ">Figure 5
<p>Effect of crude <span class="html-italic">P. rubescens</span>-dominated bloom-sample extract (-●-) and the isolated <span class="html-italic">P. rubescens</span> BGSD-500 (- <span class="html-fig-inline" id="toxins-05-02434-i001"> <img alt="Toxins 05 02434 i001" src="/toxins/toxins-05-02434/article_deploy/html/images/toxins-05-02434-i001.png"/></span>-) on the growth of <span class="html-italic">Sinapis alba</span> etiolated seedlings (Blue-Green-Sinapis-Test).</p>
Full article ">Figure 6
<p>Capillary electrophoresis of <span class="html-italic">P. rubescens</span>-dominated bloom-sample extract (A) and the isolated <span class="html-italic">P. rubescens</span> BGSD-500 (B). Peak of [<span class="html-small-caps">d</span>-Asp<sup>3</sup>, <span class="html-italic">M</span>dha<sup>7</sup>]MC–RR is indicated by black arrow. (separation conditions: capillary: 64.5 cm, 50 µm i.d., buffer electrolyte: 25 mM borate and 75 mM SDS, pH 9.3, applied voltage: +25 kV, detection: UV absorption at 238 nm).</p>
Full article ">Figure 7
<p>Localization of the detected and partly identified 1194 nt length insertion element in the spacer region between <span class="html-italic">mcy</span>T and <span class="html-italic">mcy</span>D of <span class="html-italic">mcy</span> gene cluster of <span class="html-italic">Planktothrix</span>.</p>
Full article ">
993 KiB  
Article
Preliminary Results of the in Vivo and in Vitro Characterization of a Tentacle Venom Fraction from the Jellyfish Aurelia aurita
by Dalia Ponce, Estuardo López-Vera, Manuel B. Aguilar and Judith Sánchez-Rodríguez
Toxins 2013, 5(12), 2420-2433; https://doi.org/10.3390/toxins5122420 - 6 Dec 2013
Cited by 18 | Viewed by 8357
Abstract
The neurotoxic effects produced by a tentacle venom extract and a fraction were analyzed and correlated by in vivo and in vitro approaches. The tentacle venom extract exhibited a wide range of protein components (from 24 to >225 kDa) and produced tetanic reactions, [...] Read more.
The neurotoxic effects produced by a tentacle venom extract and a fraction were analyzed and correlated by in vivo and in vitro approaches. The tentacle venom extract exhibited a wide range of protein components (from 24 to >225 kDa) and produced tetanic reactions, flaccid paralysis, and death when injected into crabs. Two chromatography fractions also produced uncontrolled appendix movements and leg stretching. Further electrophysiological characterization demonstrated that one of these fractions potently inhibited ACh-elicited currents mediated by both vertebrate fetal and adult muscle nicotinic acetylcholine receptors (nAChR) subtypes. Receptor inhibition was concentration-dependent and completely reversible. The calculated IC50 values were 1.77 ?g/?L for fetal and 2.28 ?g/?L for adult muscle nAChRs. The bioactive fraction was composed of a major protein component at ~90 kDa and lacked phospholipase A activity. This work represents the first insight into the interaction of jellyfish venom components and muscle nicotinic receptors. Full article
(This article belongs to the Collection Marine and Freshwater Toxins)
Show Figures

Figure 1

Figure 1
<p>Micrograph of <span class="html-italic">A. aurita</span> nematocysts along fishing tentacles. Atrichous ishorizas (white arrow) measured 6 × 4 µm wide and presented a disperse distribution along the tentacle tissue. Heterotrichous microbasic euryteles (black arrow) were approximately 12 × 9 µm wide and were arranged in clusters. 400× magnification, bar = 50 µm.</p>
Full article ">Figure 2
<p>Protein content and fractionation of <span class="html-italic">A. aurita</span> TVE. (<b>A</b>) SDS-PAGE protein profile of TVE was performed in 12% polyacrylamide gel stained with Coomassie brilliant blue R-250. M indicates molecular mass standards (Amersham Rainbow Marker high-range, GE Healthcare); Lane 1 corresponds to 20 μg total protein of TVE. (<b>B</b>) Chromatogram of TVE fractionation by C18 reversed-phase column using a gradient of solution B from 5% to 95% (dashed line) at a flow rate of 1 mL/min over 60 min; Baseline indicated with a thin line. (<b>C</b>) SDS-PAGE protein profile of chromatography fractions. Analysis was performed in 10% polyacrylamide gels stained with Coomassie brilliant blue R-250. M indicates molecular mass standards (Kaleidoscope, Bio-Rad); Lanes 1–10 correspond to the eluted peaks equally labeled from HPLC fractionation.</p>
Full article ">Figure 3
<p>Activity of fraction 4 on fetal muscle nAChR expressed in <span class="html-italic">X. laevis</span> oocytes. Concentration-response effects can be compared through the various panels. Arrows indicate the first current elicited after the 5 min static bath of toxin equilibration. Control membrane depolarisations elicited by 1–5 μM ACh pulses are indicated as 10% of total value (nA); (<b>A</b>) 1.5 μg total protein of fraction 4 inhibited 25% of ACh-elicited currents; (<b>B</b>) 3 μg total protein of fraction 4 blocked 50% of ACh currents; (<b>C</b>) 4.5 μg total protein of fraction 4 caused 96% blocking effect.</p>
Full article ">Figure 4
<p>Concentration-response curves for fraction 4 on the adult (up-triangle) and fetal (down-triangle) subtypes of mouse muscle nAChR. Curves were generated by plotting current amplitude after toxin application as a percentage of current amplitude prior to toxin application (% response). Each data point represents the average value ± S.E. of the responses from three oocytes.</p>
Full article ">
1026 KiB  
Article
Molecular Cloning and Pharmacological Properties of an Acidic PLA2 from Bothrops pauloensis Snake Venom
by Francis Barbosa Ferreira, Mário Sérgio Rocha Gomes, Dayane Lorena Naves De Souza, Sarah Natalie Cirilo Gimenes, Letícia Eulalio Castanheira, Márcia Helena Borges, Renata Santos Rodrigues, Kelly Aparecida Geraldo Yoneyama, Maria Inês Homsi Brandeburgo and Veridiana M. Rodrigues
Toxins 2013, 5(12), 2403-2419; https://doi.org/10.3390/toxins5122403 - 4 Dec 2013
Cited by 28 | Viewed by 7593
Abstract
In this work, we describe the molecular cloning and pharmacological properties of an acidic phospholipase A2 (PLA2) isolated from Bothrops pauloensis snake venom. This enzyme, denominated BpPLA2-TXI, was purified by four chromatographic steps and represents 2.4% of [...] Read more.
In this work, we describe the molecular cloning and pharmacological properties of an acidic phospholipase A2 (PLA2) isolated from Bothrops pauloensis snake venom. This enzyme, denominated BpPLA2-TXI, was purified by four chromatographic steps and represents 2.4% of the total snake venom protein content. BpPLA2-TXI is a monomeric protein with a molecular mass of 13.6 kDa, as demonstrated by Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) analysis and its theoretical isoelectric point was 4.98. BpPLA2-TXI was catalytically active and showed some pharmacological effects such as inhibition of platelet aggregation induced by collagen or ADP and also induced edema and myotoxicity. BpPLA2-TXI displayed low cytotoxicity on TG-180 (CCRF S 180 II) and Ovarian Carcinoma (OVCAR-3), whereas no cytotoxicity was found in regard to MEF (Mouse Embryonic Fibroblast) and Sarcoma 180 (TIB-66). The N-terminal sequence of forty-eight amino acid residues was determined by Edman degradation. In addition, the complete primary structure of 122 amino acids was deduced by cDNA from the total RNA of the venom gland using specific primers, and it was significantly similar to other acidic D49 PLA2s. The phylogenetic analyses showed that BpPLA2-TXI forms a group with other acidic D49 PLA2s from the gender Bothrops, which are characterized by a catalytic activity associated with anti-platelet effects. Full article
Show Figures

Figure 1

Figure 1
<p>Sequential purification steps of BpPLA<sub>2</sub>-TXI. (<b>A</b>) <span class="html-italic">Bothrops pauloensis</span> venom (170 mg) on CM-Sepharose Fast Flow previously equilibrated with ammonium bicarbonate (AMBIC) buffer 0.05M pH 7.8. A gradient was then applied up to 0.5 M (AMBIC) buffer, pH 7.8. Fractions of 1 mL/tube were collected in a 6 mL/h flow rate at room temperature; (<b>B</b>) CM1 (60 mg) on Sephacryl-S300 previously equilibrated and eluted with AMBIC buffer (0.05 M; pH 7.8) at a flow rate of 12.0 mL/h and fractions of 2.0 mL/tube were collected; (<b>C</b>) S4 was rechromatographed on HiTrap Q FF column, equilibrated with AMBIC (0.05 M; pH 7.8). A gradient was then applied up to the column using AMBIC buffer (0.5 M, pH 7.8) at flow rate of 6.0 mL/h and fractions of 1 mL/tube were collected; (<b>D</b>) The active fraction (Q2) on reverse phase-high performance liquid chromatography (RP-HPLC) C2–C18 and PLA<sub>2</sub> was eluted using Solvent A (0.1% TFA, 4% acetonitrile) to 100% of the Solvent B (0.1% TFA, 80% acetonitrile) at the flow rate of 0.5 mL/min for 33 min and fractions of 0.5 mL/tube; (<b>E</b>) sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) at 12% (<span class="html-italic">w</span>/<span class="html-italic">v</span>). Line 1: molecular mass markers; Line 2: acidic PLA<sub>2</sub> (BpPLA<sub>2</sub>-TXI).</p>
Full article ">Figure 2
<p>Molecular mass determination of BpPLA<sub>2</sub>-TXI by Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) (Bruker Daltonics, Bremen, Germany).</p>
Full article ">Figure 3
<p>Effects of different pH values and temperatures on phospholipase activity induced by Bp-PLA<sub>2</sub>-TxI from <span class="html-italic">Bothrops pauloensis</span> snake venom. The indirect hemolysis assay was determined by measuring the hemolytic halo in mm<sup>2</sup> after 24 h of incubation of 5 µg of BpPLA<sub>2</sub>-TXI previously incubated with different buffers (<b>A</b>) and temperatures (<b>B</b>). For all the experiments, data are expressed as means ± SEM (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 4
<p>Platelet aggregation inhibition induced by BpPLA<sub>2</sub>-TXI. Different concentrations (20, 40, 80 and 160 µg/mL) of BpPLA<sub>2</sub>-TXI were preincubated at 37 °C for 10 min under stirring with washed platelets ((3–4) × 10<sup>5</sup> cells/µL) and then platelet aggregation was initiated with ADP (20 µM) or collagen (10 µg/mL). Results are presented as percent of platelet aggregation (mean ± S.D., <span class="html-italic">n</span> = 3). Statistically significant results compared to collagen (<b>*</b>) or ADP (<sup>#</sup>) (<span class="html-italic">p</span> &lt; 0.05) are shown.</p>
Full article ">Figure 5
<p>Edema-inducing activities of BpPLA<sub>2</sub>-TXI or crude venom. Paw edema in Swiss mice after injection of BpPLA<sub>2</sub>-TXI or crude venom (10 µg/50 µL Saline). Results are reported as mean ± S.D. (<span class="html-italic">n</span> = 3). (<b>*</b>) Statistically significant results compared to saline (<span class="html-italic">p</span> &lt; 0.05) are shown.</p>
Full article ">Figure 6
<p>Myotoxic activity of BpPLA<sub>2</sub>-TXI in mice. Animals were injected i.m. with crude venom. Acidic BpPLA<sub>2</sub>-TXI or basic BnSP-7 (20 µg/50 µL Saline) and plasma CK activity was measured 3h after injection. Control mice were injected with only saline. Results are reported as mean ± S.D. (<span class="html-italic">n</span> = 3). (<b>*</b>) Statistically significant results compared to saline (<span class="html-italic">p</span> &lt; 0.05) are shown.</p>
Full article ">Figure 7
<p>Complete sequence of the cDNA coding BpPLA<sub>2</sub>-TXI. The N-terminal sequence of the mature protein obtained by the Edman method is underlined. The initial region corresponds to the signal peptide. The symbol (<b>*</b>) represents the stop codon.</p>
Full article ">Figure 8
<p>Multiple alignment of BpPLA<sub>2</sub>-TXI from <span class="html-italic">B. pauloensis</span> and the most similar PLA<sub>2</sub> (acidic and basic; D49 and K49) sequences (by protein blast) from other snake venoms using ClustalW program. The cysteine residues are marked in grey. The symbol (<b>*</b>) represents conserved amino acid residues in all analyzed sequences. The symbol (<b>–</b>) represents gaps introduced in the sequences to maximize the alignment. The symbols (<b>:</b>) and (<b>.</b>) represent amino acid residues with same and different chemical characteristics, respectively. (ABC96692.1 <span class="html-italic">Bothropoides erythromelas</span>; AAO27454.1 and AAN37410.1 <span class="html-italic">Bothrops jararacussu</span>; AAR14163.1, ABG26993.1 and AAS79431.1 <span class="html-italic">Sistrurus catenatus</span>; AAM09694.1 <span class="html-italic">Bothropoides insularis</span>; AAW92118.1 <span class="html-italic">Cerrophidion godmani</span>; AAW92121.1 <span class="html-italic">Trimeresurus gracilis</span>; AAM80563.1 and AAM80565.1 <span class="html-italic">Crotalus viridis viridis</span>; BAA08383.1 <span class="html-italic">Ovophis okinavensis</span>; BAA01568.1 <span class="html-italic">Protobothrops flavoviridis</span>; AAP48897.1, AAP48894.1 and AAP48892.1 <span class="html-italic">Viridovipera stejnegeri</span>; AAW92117.1 <span class="html-italic">Bothriechis schlegelii</span>; AAB71849.1 <span class="html-italic">Gloydius halys</span>; ADB77855.1 <span class="html-italic">Lachesis muta</span>; BAA06553.1 <span class="html-italic">Trimeresurus gramineus</span>.</p>
Full article ">Figure 9
<p>Evolutionary PLA<sub>2</sub> relationships. The evolutionary history was inferred using the neighbor-joining method. Phylogenetic analyses were conducted by the program MrBayes. The PLA<sub>2</sub>s from snake venoms (deposited in GenBank) were grouped into two branches (acidic and basic); those shown inside the box are D49 PLA<sub>2</sub> and those outside the box are K49. Human Synovial PLA<sub>2</sub> (NCBI: AAH05919.1) sequence was included as outside group.</p>
Full article ">
343 KiB  
Article
Different Assay Conditions for Detecting the Production and Release of Heat-Labile and Heat-Stable Toxins in Enterotoxigenic Escherichia coli Isolates
by Letícia B. Rocha, Christiane Y. Ozaki, Denise S. P. Q. Horton, Caroline A. Menezes, Anderson Silva, Irene Fernandes, Fabio C. Magnoli, Tania M. I. Vaz, Beatriz E. C. Guth and Roxane M. F. Piazza
Toxins 2013, 5(12), 2384-2402; https://doi.org/10.3390/toxins5122384 - 2 Dec 2013
Cited by 16 | Viewed by 7954
Abstract
Enterotoxigenic Escherichia coli (ETEC) produce heat-labile (LT) and/or heat-stable enterotoxins (ST). Despite that, the mechanism of action of both toxins are well known, there is great controversy in the literature concerning the in vitro production and release of LT and, for ST, no [...] Read more.
Enterotoxigenic Escherichia coli (ETEC) produce heat-labile (LT) and/or heat-stable enterotoxins (ST). Despite that, the mechanism of action of both toxins are well known, there is great controversy in the literature concerning the in vitro production and release of LT and, for ST, no major concerns have been discussed. Furthermore, the majority of published papers describe the use of only one or a few ETEC isolates to define the production and release of these toxins, which hinders the detection of ETEC by phenotypic approaches. Thus, the present study was undertaken to obtain a better understanding of ST and LT toxin production and release under laboratory conditions. Accordingly, a collection of 90 LT-, ST-, and ST/LT-producing ETEC isolates was used to determine a protocol for toxin production and release aimed at ETEC detection. For this, we used previously raised anti-LT antibodies and the anti-ST monoclonal and polyclonal antibodies described herein. The presence of bile salts and the use of certain antibiotics improved ETEC toxin production/release. Triton X-100, as chemical treatment, proved to be an alternative method for toxin release. Consequently, a common protocol that can increase the production and release of LT and ST toxins could facilitate and enhance the sensitivity of diagnostic tests for ETEC using the raised and described antibodies in the present work. Full article
(This article belongs to the Special Issue Advances in Toxin Detection)
Show Figures

Figure 1

Figure 1
<p>Reactivity of ST MAb by immunoblotting. Bacterial lysates from strains 30 (Lane 1), 127 (Lane 2), and 3321-4 (Lane 3) (3 µg) were separated by SDS-PAGE (10% gel; tricine) and transferred to a PVDF membrane. Each strip was incubated with anti-ST MAb followed by goat anti-mouse IgG peroxidase-conjugate. Immunodetection signals were visualized by addition of DAB/H<sub>2</sub>O<sub>2</sub>. Molecular markers are indicated as kilodaltons (kDa) at the left side of the panel. The arrow indicates the pre-pro-peptide form of ST toxin. ETEC isolates 30 and 127 had spontaneously lost the <span class="html-italic">estA</span> gene.</p>
Full article ">Figure 2
<p>LT (<b>A</b>) and ST (<b>B</b>) production after chemical treatments. The ETEC H10407 strain was cultivated in EC broth. After 16–18 h, the culture was centrifuged and cell pellets were treated with 0.1 M EDTA or 0.2 mg/mL polymyxin B sulfate (1606 UI/mL) or 2% triton X-100 (small checkered) or not (white bars). The same compounds were also added directly to the culture growth (large checkered) or not (white bars) and then centrifuged. The supernatants treated or not were tested for LT (<b>A</b>) or for ST (<b>B</b>) by cELISA. The error bars represent the absorbance means and standard errors of duplicates of three independent experiments.</p>
Full article ">Figure 3
<p>LT (<b>A</b>) and ST (<b>B</b>) production in presence or absence of antibiotics. The ETEC H10407 strain was cultivated in EC broth containing lincomycin (black line), ciprofloxacin (green line), lincomycin plus ciprofloxacin (red line) or no antibiotic (blue line). The supernatants were tested for LT (<b>A</b>) by cELISA or for ST (<b>B</b>) by indirect ELISA.</p>
Full article ">Figure 4
<p><span class="html-italic">In vitro</span> effects of lincomycin and ciprofloxacin on enterotoxigenic <span class="html-italic">Escherichia coli</span> isolates. (<b>A</b>) LT-producing strains. (<b>B</b>) ST/LT-producing strains. The strains were cultivated in EC broth (○/white bars) or EC broth containing lincomycin and ciprofloxacin (●/crosshatched bars), and bacterial growth cultures were treated with 2% triton X-100. Each supernatant was tested for LT by cELISA.</p>
Full article ">Figure 5
<p><span class="html-italic">In vitro</span> effects of lincomycin and ciprofloxacin on enterotoxigenic <span class="html-italic">Escherichia coli</span> isolates. (<b>A</b>) ST-producing strains. (<b>B</b>) ST/LT-producing strains. The strains were cultivated in EC broth (○/white bars) or EC broth containing lincomycin and ciprofloxacin (●/crosshatched bars), and the bacterial growth cultures were treated with 2% triton X-100. Each supernatant was tested for ST by cELISA.</p>
Full article ">
1151 KiB  
Review
Biotoxin Detection Using Cell-Based Sensors
by Pratik Banerjee, Spyridon Kintzios and Balabhaskar Prabhakarpandian
Toxins 2013, 5(12), 2366-2383; https://doi.org/10.3390/toxins5122366 - 29 Nov 2013
Cited by 49 | Viewed by 15189
Abstract
Cell-based biosensors (CBBs) utilize the principles of cell-based assays (CBAs) by employing living cells for detection of different analytes from environment, food, clinical, or other sources. For toxin detection, CBBs are emerging as unique alternatives to other analytical methods. The main advantage of [...] Read more.
Cell-based biosensors (CBBs) utilize the principles of cell-based assays (CBAs) by employing living cells for detection of different analytes from environment, food, clinical, or other sources. For toxin detection, CBBs are emerging as unique alternatives to other analytical methods. The main advantage of using CBBs for probing biotoxins and toxic agents is that CBBs respond to the toxic exposures in the manner related to actual physiologic responses of the vulnerable subjects. The results obtained from CBBs are based on the toxin-cell interactions, and therefore, reveal functional information (such as mode of action, toxic potency, bioavailability, target tissue or organ, etc.) about the toxin. CBBs incorporate both prokaryotic (bacteria) and eukaryotic (yeast, invertebrate and vertebrate) cells. To create CBB devices, living cells are directly integrated onto the biosensor platform. The sensors report the cellular responses upon exposures to toxins and the resulting cellular signals are transduced by secondary transducers generating optical or electrical signals outputs followed by appropriate read-outs. Examples of the layout and operation of cellular biosensors for detection of selected biotoxins are summarized. Full article
(This article belongs to the Special Issue Advances in Toxin Detection)
Show Figures

Figure 1

Figure 1
<p>Generalized working principle of cellular sensors.</p>
Full article ">Figure 2
<p>Schematic design of CBB prototypes used for detection several hemolytic/cytolytic toxins. (<b>a</b>) A centrifugal filtration tube unit-based biosensor device and the sequence of operations; (<b>b</b>) A hand-held µ-Slide device prototype. Samples containing different toxins were introduced into the sample chambers followed by detection using a colorimetric alkaline phosphatase enzyme assay. Adopted with some modifications from [<a href="#B10-toxins-05-02366" class="html-bibr">10</a>].</p>
Full article ">Figure 3
<p>Overall strategy of cell-based biosensing exploiting cytotoxicity of select toxins. Cells with appropriate recognition elements (often membrane receptors) respond to respective toxins which result in cytotoxicity.</p>
Full article ">Figure 4
<p>Detection scheme of botulinum neurotoxins A (BoNT/A) using a CBB coupled with a sandwich ELISA. In this cell-based potency assay, a sensitive and rapid screening (in italics) of BoNT/A was achieved using differentiated human neuroblastoma SiMa cells. Reproduced from [<a href="#B85-toxins-05-02366" class="html-bibr">85</a>] under the terms of the Creative Commons Attribution License.</p>
Full article ">
1414 KiB  
Article
An Extract of Rhodobacter sphaeroides Reduces Cisplatin-Induced Nephrotoxicity in Mice
by Wen-Wei Chang, Jau-Jin Liu, Chi-Fan Liu, Wen-Sheng Liu, Yun-Ping Lim, Yu-Jung Cheng and Che-Hsin Lee
Toxins 2013, 5(12), 2353-2365; https://doi.org/10.3390/toxins5122353 - 29 Nov 2013
Cited by 22 | Viewed by 6461
Abstract
Cisplatin is used as a treatment for various types of solid tumors. Renal injury severely limits the use of cisplatin. Renal cell apoptosis, oxidative stress, and inflammation contribute to cisplatin-induced nephrotoxicity. Previously, we found that an extract of Rhodobacter sphaeroides (Lycogen™) inhibited proinflammatory [...] Read more.
Cisplatin is used as a treatment for various types of solid tumors. Renal injury severely limits the use of cisplatin. Renal cell apoptosis, oxidative stress, and inflammation contribute to cisplatin-induced nephrotoxicity. Previously, we found that an extract of Rhodobacter sphaeroides (Lycogen™) inhibited proinflammatory cytokines and the production of nitric oxide in activated macrophages in a dextran sodium sulfate (DSS)-induced colitis model. Here, we evaluated the effect of Lycogen™, a potent anti-inflammatory agent, in mice with cisplatin-induced renal injury. We found that attenuated renal injury correlated with decreased apoptosis due to a reduction in caspase-3 expression in renal cells. Oral administration of Lycogen™ significantly reduced the expression of tumor necrosis factor-? and interleukin-1? in mice with renal injury. Lycogen™ reduces renal dysfunction in mice with cisplatin-induced renal injury. The protective effects of the treatment included blockage of the cisplatin-induced elevation in serum urea nitrogen and creatinine. Meanwhile, Lycogen™ attenuated body weight loss and significantly prolonged the survival of mice with renal injury. We propose that Lycogen™ exerts anti-inflammatory activities that represent a promising strategy for the treatment of cisplatin-induced renal injury. Full article
Show Figures

Figure 1

Figure 1
<p>The effects of Lycogen™ and cisplatin on the viability of mesangial cells (MES-13). MES-13 cells were treated with the indicated concentrations of Lycogen™ or cisplatin for 48 h. Cell viability was measured after (<b>A</b>) Lycogen™ treatment or (<b>B</b>) cisplatin treatment using a WST-1 assay. <b>***</b> <span class="html-italic">p</span> &lt; 0.001 (mean ± SD, <span class="html-italic">n</span> = 6). Each experiment was repeated three times with similar results.</p>
Full article ">Figure 2
<p>Lycogen™ reduced cisplatin-induced cell apoptosis. MES-13 cells were pretreated with Lycogen™ at concentration of 0, 2, 4, 8 or 16 μM for 48 h. Next, cisplatin (5 μg/mL) was added to the cells for 48 h. (<b>A</b>) Cell viability was measured using a WST-1 assay; (<b>B</b>) The expression of nuclear p53 and caspase 3 was measured by Western blot analysis. Proliferating cell nuclear antigen (PCNA) and β-actin expression served as loading controls for nuclear proteins and total proteins, respectively. Inserted values indicate the relative protein expression when compared with pro-caspase 3. <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01, <b>***</b> <span class="html-italic">p</span> &lt; 0.001 (mean ± SD, <span class="html-italic">n</span> = 6); (<b>C</b>) TNF-α secreted by MES-13 cells is mediated by TLR4 signaling. The cells were preincubated with anti-TLR4 or with control IgG, and then treated with or without Lycogen™ for 48 h. TNF-α was measured using an enzyme-linked immunosorbent assay. Each experiment was repeated three times with similar results.</p>
Full article ">Figure 3
<p>Lycogen™ ameliorated cisplatin-induced renal dysfunction. Mice were treated with Lycogen™ (1 mg/kg) for three consecutive days, starting on day 0. Mice were given an intraperitoneal injection (i.p.) of cisplatin (30 mg/kg) on day 3. Control mice received PBS. The effect of Lycogen™ on (<b>A</b>) creatinine and (<b>B</b>) blood urine nitrogen (BUN) levels 72 h after cisplatin administration. <b>*</b> <span class="html-italic">p</span> &lt; 0.05 (mean ± SD, <span class="html-italic">n</span> = 4). (<b>C</b>) Sections of kidney were stained with PAS or TUNEL 72 h after the cisplatin injection. The arrows indicate the location of positive TUNEL staining in the kidney. Each experiment was repeated three times with similar results.</p>
Full article ">Figure 4
<p>Lycogen™ ameliorated cisplatin-induced renal inflammation. Mice were treated with Lycogen™ (1 mg/kg) for three consecutive days starting on day 0. Next, mice were injected i.p. with cisplatin (30 mg/kg) on day 3. Control mice received PBS. (<b>A</b>) TNF-α and (<b>B</b>) IL-1β levels in the sera as measured by ELISA 72 h after cisplatin treatment. <b>*</b> <span class="html-italic">p</span> &lt; 0.05 (mean ± SD, <span class="html-italic">n</span> = 4). (<b>C</b>) Lycogen™ reduced cytokine expression in the kidney. A portion of the mice received Lycogen™ treatment. After three days, mice were killed, kidneys were collected, and the renal lysates were analyzed for TNF-α and IL-1β expression using immunoblot analysis. Each experiment was repeated three times with similar results.</p>
Full article ">Figure 5
<p>The effect of Lycogen™ on cisplatin-induced renal injury in mice. (<b>A</b>) The mice were orally administered Lycogen™ (1 mg/kg) for three consecutive days after an i.p. injection of cisplatin (30 mg/kg) and the body weight of mice was recorded daily (mean ± SD, <span class="html-italic">n</span> = 8, <b>*</b> <span class="html-italic">p</span> &lt; 0.01 for cisplatin-induced renal injury mice pretreated with Lycogen™ <span class="html-italic">versus</span> cisplatin-induced renal injury mice pretreated with PBS); (<b>B</b>) Kaplan-Meier survival curves up to day 14 are shown (<span class="html-italic">n</span> = 8). Significant differences between continuous variables was assessed using Student’s t-test. Mice survival analysis was performed using the Kaplan-Meier survival curve and log-rank test. <b>*</b> <span class="html-italic">p</span> &lt; 0.05, <b>**</b> <span class="html-italic">p</span> &lt; 0.01; (<b>C</b>) The mice were injected i.p. with cisplatin (30 mg/kg) and then orally administered Lycogen™ (1 mg/kg) for three consecutive days beginning 16 h after the cisplatin administration. The body weights of mice were recorded (mean ± SD, <span class="html-italic">n</span> = 8); (<b>D</b>) Kaplan-Meier survival curves up to day 14 are shown (<span class="html-italic">n</span> = 8).</p>
Full article ">
723 KiB  
Article
Deoxynivanelol and Fumonisin, Alone or in Combination, Induce Changes on Intestinal Junction Complexes and in E-Cadherin Expression
by Karina Basso, Fernando Gomes and Ana Paula Loureiro Bracarense
Toxins 2013, 5(12), 2341-2352; https://doi.org/10.3390/toxins5122341 - 28 Nov 2013
Cited by 47 | Viewed by 7072
Abstract
Fusariotoxins such as fumonisin B1 (FB1) and deoxynivalenol (DON) cause deleterious effects on the intestine of pigs. The aim of this study was to evaluate the effect of these mycotoxins, alone and in combination, on jejunal explants from piglets, using histological, immunohistochemical and [...] Read more.
Fusariotoxins such as fumonisin B1 (FB1) and deoxynivalenol (DON) cause deleterious effects on the intestine of pigs. The aim of this study was to evaluate the effect of these mycotoxins, alone and in combination, on jejunal explants from piglets, using histological, immunohistochemical and ultrastructural assays. Five 24-day old pigs were used for sampling the explants. Forty-eight explants were sampled from each animal. Explants were incubated for 4 hours in culture medium and medium containing FB1 (100 µM), DON (10 µM) and both mycotoxins (100 µM FB1 plus 10 µM DON). Exposure to all treatments induced a significant decrease in the normal intestinal morphology and in the number of goblet cells, which were more severe in explants exposed to DON and both mycotoxins. A significant reduction in villus height occurred in groups treated with DON and with co-contamination. Expression of E-cadherin was significantly reduced in explants exposed to FB1 (40%), DON (93%) and FB1 plus DON (100%). The ultrastructural assay showed increased intercellular spaces and no junction complexes on enterocytes exposed to mycotoxins. The present data indicate that FB1 and DON induce changes in cell junction complexes that could contribute to increase paracellular permeability. The ex vivo model was adequate for assessing intestinal toxicity induced by exposure of isolated or associated concentrations of 100 µM of FB1 and 10 µM of DON. Full article
(This article belongs to the Special Issue Recent Advances and Perspectives in Deoxynivalenol Research)
Show Figures

Figure 1

Figure 1
<p>Effects of individual and combined exposition of jejunal explants to fumonisin and deoxynivalenol on histology. Explants were exposed to culture medium ( <span class="html-fig-inline" id="toxins-05-02341-i001"> <img alt="Toxins 05 02341 i001" src="/toxins/toxins-05-02341/article_deploy/html/images/toxins-05-02341-i001.png"/></span>) or culture medium with fumonisin B1 (FB1) ( <span class="html-fig-inline" id="toxins-05-02341-i002"> <img alt="Toxins 05 02341 i002" src="/toxins/toxins-05-02341/article_deploy/html/images/toxins-05-02341-i002.png"/></span>), deoxynivalenol (DON) ( <span class="html-fig-inline" id="toxins-05-02341-i003"> <img alt="Toxins 05 02341 i003" src="/toxins/toxins-05-02341/article_deploy/html/images/toxins-05-02341-i003.png"/></span>) or FB1 + DON (■). (<b>A</b>) Control explants. Edema of the lamina propria and mild villi atrophy (arrow); (<b>B</b>) FB1-exposed explant. Moderate fusion (arrow) and villous atrophy; (<b>C</b>) DON-exposed explant. Severe loss of apical enterocytes, fusion and atrophy (arrow); (<b>D</b>) FB1 + DON-exposed explant. Lysis of intestinal epithelium, villi atrophy, fusion (arrow) and cell debris. HE. Bar 100 µm; (<b>E</b>) Control explant showing a strong and homogeneous E-cadherin expression. Bar 20 µm; (<b>F</b>) DON-exposed explant showing reduced expression of E-cadherin. Bar 20 µm; (<b>G</b>) Tissue scores of pig intestinal explants exposed to FB1, DON and both mycotoxins; (<b>H</b>) Villi height in pig intestinal explants treated with FB1, DON and FB1 + DON; (I) Number of goblet cells per villus of pig intestinal explants treated with FB1, DON and FB1 + DON. Values are means with their standard deviation of the mean represented by vertical bars (<span class="html-italic">n</span> 5 animals). Mean values with unlike letters were significantly different (<span class="html-italic">p</span> ≤ 0.05). AU = Arbitrary Units.</p>
Full article ">Figure 2
<p>Effects of individual and combined exposition of jejunal explants to fumonisin and deoxynivalenol on ultrastructure. (<b>A</b>) Control explant. Enterocytes with normal morphology of microvilli and cytoplasm. Bar 500 nm; (<b>B</b>) Control explant. Enterocytes with junction complexes (arrow) and glycogen granules scattered in the cytoplasm. Bar 2 nm; (<b>C</b>) FB1-exposed explant. Focal loss of apical enterocytes (arrow head) and loss of microvilli (arrow). Bar 2 nm; (<b>D</b>) DON-exposed explant. Increased intercellular space (arrow) and loss of junction complexes. Bar 5 nm; (<b>E</b>) DON-exposed explant. Vacuoles within cytoplasm, membrane blebs and loss of apical enterocytes. Bar 10 nm.</p>
Full article ">
327 KiB  
Article
Impact of pH on the Stability and the Cross-Reactivity of Ochratoxin A and Citrinin
by Ingrid Bazin, Virginie Faucet-Marquis, Marie-Carmen Monje, Micheline El Khoury, Jean-Louis Marty and Annie Pfohl-Leszkowicz
Toxins 2013, 5(12), 2324-2340; https://doi.org/10.3390/toxins5122324 - 28 Nov 2013
Cited by 41 | Viewed by 8999
Abstract
Mycotoxins are secondary metabolites produced by several fungi contaminating crops. In several countries, the maximum permitted levels of mycotoxins are found in foodstuffs and feedstuffs. The common strategy of mycotoxin analysis involves extraction, clean-up and quantification by chromatography. In this paper, we analyzed [...] Read more.
Mycotoxins are secondary metabolites produced by several fungi contaminating crops. In several countries, the maximum permitted levels of mycotoxins are found in foodstuffs and feedstuffs. The common strategy of mycotoxin analysis involves extraction, clean-up and quantification by chromatography. In this paper, we analyzed the reasons of underestimation of ochratoxin A (OTA) content in wine, and overestimation of OTA in wheat, depending on the pH of the clean-up step and the simultaneous presence of citrinin (CIT). We demonstrated that the increase of pH by adding polyethylene glycol (PEG) to wine led to an underestimation of OTA by conversion of OTA into open ring ochratoxin A OP-OA. In comparing three methods of extraction and clean-up for the determination of OTA and CIT in wheat—(i) an inter-laboratory validated method for OTA in cereals using immunoaffinity column clean-up (IAC) and extraction by acetonitrile/water; (ii) a validated method using IAC and extraction with 1% bicarbonate Na; and (iii) an in-house validated method based on acid liquid/liquid extraction—we observed an overestimation of OTA after immunoaffinity clean-up when CIT is also present in the sample, whereas an underestimation was observed when OTA was alone. Under neutral and alkaline conditions, CIT was partially recognized by OTA antibodies. Full article
(This article belongs to the Special Issue Recent Advances in Ochratoxins Research)
Show Figures

Figure 1

Figure 1
<p>Chemical structure of ochratoxin A (OTA).</p>
Full article ">Figure 2
<p>Chemical structure of citrinin, existing in both forms.</p>
Full article ">Figure 3
<p>UV-Spectra of ochratoxin A: Curve A represents the spectrum of OTA at pH 4. Curve B represents the spectrum of OTA at pH 7. Curve C represents the spectrum of OTA at pH 8. Curve D represents the spectrum of OTA at pH 12.</p>
Full article ">Figure 4
<p>UV-Spectra of citrinin and ochratoxin A in mixture: Curve A represents the spectrum of CIT at four pH (4, 7, 8 and 12). Curve B represents the spectrum of CIT in mixture with OTA at pH 4. Curve C represents the spectrum of CIT in mixture with OTA at pH 7. Curve D represents the spectrum of CIT in mixture with OTA at pH 8.</p>
Full article ">Figure 5
<p>Ring opening of OTA (OP-OA) under alkaline conditions adapted from [<a href="#B50-toxins-05-02324" class="html-bibr">50</a>,<a href="#B51-toxins-05-02324" class="html-bibr">51</a>,<a href="#B52-toxins-05-02324" class="html-bibr">52</a>].</p>
Full article ">Figure 6
<p>Ring opening of citrinin (citrinin H2) induced by increase of pH [<a href="#B56-toxins-05-02324" class="html-bibr">56</a>].</p>
Full article ">Figure 7
<p>HPLC separation of OTA metabolites from the mixture of OTA and citrinin in aqueous solution.</p>
Full article ">
1696 KiB  
Article
Influence of Fermentation and Drying Materials on the Contamination of Cocoa Beans by Ochratoxin A
by Sébastien Djédjé Dano, Pierre Manda, Ardjourma Dembélé, Ange Marie-Joseph Kouassi Abla, Joel Henri Bibaud, Julien Zroh Gouet and Charles Bruno Ze Maria Sika
Toxins 2013, 5(12), 2310-2323; https://doi.org/10.3390/toxins5122310 - 28 Nov 2013
Cited by 20 | Viewed by 8768
Abstract
Ochratoxin A (OTA) is a mycotoxin produced mainly by species of Aspergillus and Penicillium. Contamination of food with OTA is a major consumer health hazard. In Cote D’Ivoire, preventing OTA contamination has been the subject of extensive study. The current study was [...] Read more.
Ochratoxin A (OTA) is a mycotoxin produced mainly by species of Aspergillus and Penicillium. Contamination of food with OTA is a major consumer health hazard. In Cote D’Ivoire, preventing OTA contamination has been the subject of extensive study. The current study was conducted to evaluate the influence of fermentation and drying materials on the OTA content in cocoa. For each test, 7000 intact cocoa pods were collected, split open to remove the beans, fermented using 1 of 3 different materials, sun-dried on 1 of 3 different platform types and stored for 30 days. A total of 22 samples were collected at each stage of post-harvesting operations. The OTA content in the extracted samples was then quantified by high-performance liquid chromatography. OTA was detected in beans at all stages of post-harvesting operations at varying levels: pod-opening (0.025 ± 0.02 mg/kg), fermentation (0.275 ± 0.2 mg/kg), drying (0.569 ± 0.015 mg/kg), and storage (0.558 ± 0.04 mg/kg). No significant relationships between the detected OTA level and the materials used in the fermentation and drying of cocoa were observed. Full article
Show Figures

Figure 1

Figure 1
<p>7000 intact pods assembled for one sampling event.</p>
Full article ">Figure 2
<p>The results of fermentation on banana leaves.</p>
Full article ">Figure 3
<p>Cocoa beans in wooden boxes.</p>
Full article ">Figure 4
<p>Cocoa beans on black tarpaulin.</p>
Full article ">Figure 5
<p>Drying platforms used in this study: drying rack table (<b>a</b>), concrete floor (<b>b</b>), and black tarpaulin (<b>c</b>).</p>
Full article ">Figure 6
<p>Storage of dried cocoa beans.</p>
Full article ">Figure 7
<p>Sampling points. RT: rack table; BT: black tarpaulin; CF: concrete floor; ST: storage.</p>
Full article ">
272 KiB  
Article
Exposure Assessment for Italian Population Groups to Deoxynivalenol Deriving from Pasta Consumption
by Carlo Brera, Valentina Bertazzoni, Francesca Debegnach, Emanuela Gregori, Elisabetta Prantera and Barbara De Santis
Toxins 2013, 5(12), 2293-2309; https://doi.org/10.3390/toxins5122293 - 26 Nov 2013
Cited by 19 | Viewed by 6222
Abstract
Four hundred and seventy-two pasta samples were collected from long retail distribution chain sales points located in North, Central and South Italy. Representative criteria in the sample collection were followed in terms of number of samples collected, market share, and types of pasta. [...] Read more.
Four hundred and seventy-two pasta samples were collected from long retail distribution chain sales points located in North, Central and South Italy. Representative criteria in the sample collection were followed in terms of number of samples collected, market share, and types of pasta. Samples were analysed by an accredited HPLC-UV method of analysis. The mean contamination level (64.8 ?g/kg) of deoxynivalenol (DON) was in the 95th percentile (239 ?g/kg) and 99th percentile (337 ?g/kg), far below the legal limit (750 ?g/kg) set by Regulation EC/1126/2007, accounting for about one tenth, one third and half the legal limit, respectively. Ninety-nine percent of samples fell below half the legal limit. On the basis of the obtained occurrence levels and considering the consumption rates reported by the Italian official database, no health concern was assessed for all consumer groups, being that exposure was far below the Tolerable Daily Intake (TDI) of 1000 ng/kg b.w/day. Nevertheless, despite this, particular attention should be devoted to the exposure to DON by high consumers, such as children aged 3–5 years, who could reach the TDI even with very low levels of DON contamination. Full article
(This article belongs to the Special Issue Recent Advances and Perspectives in Deoxynivalenol Research)
Show Figures

Figure 1

Figure 1
<p>Chemical structure of deoxynivalenol (DON).</p>
Full article ">Figure 2
<p>DON exposure for a consumption of pasta of 59.8 g (mean consumption of pasta by children between 3 and 9.9 years old, [<a href="#B45-toxins-05-02293" class="html-bibr">45</a>]) at a contamination level of 750 µg/kg.</p>
Full article ">Figure 3
<p>DON exposure for a consumption of pasta of 161.7 g (99th percentile of consumption of children between 3 and 9.9 years old, [<a href="#B45-toxins-05-02293" class="html-bibr">45</a>]) at a contamination level of 750 µg/kg.</p>
Full article ">
Previous Issue
Next Issue
Back to TopTop